Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Breast J

Retrieve available abstracts of 541 articles:
HTML format



Single Articles


    March 2021
  1. JAMALUDDIN MF, Abraham AG, Menon G, Nakatsui T, et al
    Recurrent radiation recall dermatitis 40 years after radiation therapy for breast cancer.
    Breast J. 2021 Mar 24. doi: 10.1111/tbj.14212.
    PubMed     Abstract available


  2. LAROIYA I, Irrinki S, Subbhiah Nagaraj S, Sakaray YR, et al
    Triple-negative breast cancer and factors affecting disease-free survival-Experience from a tertiary care center in India.
    Breast J. 2021 Mar 21. doi: 10.1111/tbj.14227.
    PubMed    


  3. LEHRBERG A, Davis MB, Baidoun F, Petersen L, et al
    Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype.
    Breast J. 2021 Mar 18. doi: 10.1111/tbj.14225.
    PubMed     Abstract available


  4. SILIQUINI GP, Bounous VE, Novara L, Giorgi M, et al
    Fractional CO(2) vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors.
    Breast J. 2021 Mar 16. doi: 10.1111/tbj.14211.
    PubMed     Abstract available


  5. MA SJ, Yu B, Oladeru OT, Bartl AJ, et al
    Evaluation of adjuvant radiation and endocrine therapy in elderly patients with early-stage breast cancer.
    Breast J. 2021 Mar 15. doi: 10.1111/tbj.14228.
    PubMed    


  6. WEISS A, Cooley V, Al-Hilli Z, Ballman K, et al
    Extrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providers.
    Breast J. 2021 Mar 15. doi: 10.1111/tbj.14226.
    PubMed     Abstract available


  7. ANDERSON JD, Hammond JB, Kosiorek HE, Thorpe CS, et al
    Unplanned implant removal in locally advanced breast cancer.
    Breast J. 2021 Mar 14. doi: 10.1111/tbj.14224.
    PubMed     Abstract available


  8. ROBERSON PNE, Cortez G, Lenger K, Bell C, et al
    Quality of life fluctuations before and after breast surgery for estrogen-positive breast cancer patients living in South-Central Appalachia: A prospective pilot study.
    Breast J. 2021 Mar 11. doi: 10.1111/tbj.14183.
    PubMed    


  9. LOHANI KR, Kumar C, Kataria K, Srivastava A, et al
    Role of tranexamic acid in axillary lymph node dissection in breast cancer patients: Does it help in reducing lymphedema?
    Breast J. 2021 Mar 11. doi: 10.1111/tbj.14222.
    PubMed    


  10. KIZILTAN G, Bozdogan N, Ozaslan C
    Breast cancer metastasis into thyroid papillary microcarcinoma: A case report.
    Breast J. 2021 Mar 10. doi: 10.1111/tbj.14219.
    PubMed     Abstract available


  11. BARBA M, Krasniqi E, Pizzuti L, Mazzotta M, et al
    COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience.
    Breast J. 2021 Mar 6. doi: 10.1111/tbj.14204.
    PubMed     Abstract available


  12. MISHRA S, Handa G
    Role of tranexamic acid in axillary lymph node dissection in breast cancer patients: Does it help in reducing lymphedema?
    Breast J. 2021 Mar 5. doi: 10.1111/tbj.14207.
    PubMed    


  13. ROY E, Hall J, Zhu X, Egro FM, et al
    The impact of autologous versus implant-based breast reconstruction on body mass index in breast cancer patients.
    Breast J. 2021 Mar 3. doi: 10.1111/tbj.14214.
    PubMed    


    February 2021
  14. MEYER HJ, Wienke A, Surov A
    Diffusion weighted imaging to predict nodal status in breast cancer: A systematic review and meta-analysis.
    Breast J. 2021 Feb 21. doi: 10.1111/tbj.14200.
    PubMed    


  15. FILIZOGLU N, Ones T, Kesim S, Ozguven S, et al
    Paraneoplastic cerebellar degeneration: Initial presentation of occult breast cancer.
    Breast J. 2021 Feb 21. doi: 10.1111/tbj.14203.
    PubMed    


  16. TSENG J, Alban RF, Siegel E, Chung A, et al
    Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial.
    Breast J. 2021 Feb 14. doi: 10.1111/tbj.14191.
    PubMed     Abstract available


  17. KANANA N, Ben David MA, Nissan N, Yagil Y, et al
    Post-mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high-risk breast cancer patients.
    Breast J. 2021 Feb 11. doi: 10.1111/tbj.14190.
    PubMed     Abstract available


  18. RAMDANI H, El Haddad S, Chat L, Souadka A, et al
    Axillary schwannoma mimicking a breast cancer lymph node metastasis.
    Breast J. 2021 Feb 3. doi: 10.1111/tbj.14188.
    PubMed    


  19. SITTENFELD SMC, Greenberg Z, Al-Hilli Z, Abraham J, et al
    Reducing time to treatment and patient costs with breast cancer: the impact of patient visits.
    Breast J. 2021 Feb 3. doi: 10.1111/tbj.14174.
    PubMed     Abstract available


  20. BITENCOURT AGV, Felipe VC, Doi M, Graziano L, et al
    Susceptibility artifact at breast MRI due to retained fragment of localization hook-wire hiding breast cancer.
    Breast J. 2021 Feb 2. doi: 10.1111/tbj.14180.
    PubMed    


  21. DINNEEN K, O'Brien C, Quinn CM, Sweeney EL, et al
    Management of the axilla post-neoadjuvant chemotherapy in node positive breast cancer: Can the combination of axillary ultrasound and tumor biomarkers improve patient selection for sentinel node biopsy?
    Breast J. 2021 Feb 2. doi: 10.1111/tbj.14184.
    PubMed    


  22. FEIG SA
    Prospects for the use of automated whole breast ultrasound: In planning and monitoring breast cancer treatment.
    Breast J. 2021 Feb 1. doi: 10.1111/tbj.14181.
    PubMed    


  23. BABAEE E, Nojomi M, Janani L, Tehrani-Banihashem A, et al
    Intraoperative radiation therapy or external whole-breast irradiation, which is more effective in controlling the local recurrence of breast cancer? A Weibull regression model.
    Breast J. 2021 Feb 1. doi: 10.1111/tbj.14138.
    PubMed    


    January 2021
  24. BHARGAVAN RV, Augustine P, Krishna JKM, Radhakrishnan N, et al
    Sentinel node biopsy in post-neoadjuvant chemotherapy breast cancer patients using preoperative breast tattooing-A novel technique.
    Breast J. 2021 Jan 28. doi: 10.1111/tbj.14167.
    PubMed    


  25. ALAIDY Z, Mohamed A, Euhus D
    Breast cancer progression when definitive surgery is delayed.
    Breast J. 2021 Jan 27. doi: 10.1111/tbj.14177.
    PubMed     Abstract available


  26. SROUR MK, Lee M, Wolcott-Sapp S, Luu M, et al
    Incidental radiologic findings in breast cancer patients who undergo staging prior to neo-adjuvant chemotherapy.
    Breast J. 2021 Jan 25. doi: 10.1111/tbj.14172.
    PubMed     Abstract available


  27. BARCO I, Garcia-Font M, Garcia-Fernandez A, Fraile M, et al
    Breast cancer patients developing distant metastasis at follow-up: Mortality-related factors.
    Breast J. 2021 Jan 22. doi: 10.1111/tbj.14159.
    PubMed    


  28. ALQATTAN AS, Ghulam WZ, Aldaoud N, Algheryafi L, et al
    Breast fat necrosis secondary to warfarin-induced calciphylaxis, a rare mimicker of breast cancer: A case report and a review of literature.
    Breast J. 2021 Jan 21. doi: 10.1111/tbj.14160.
    PubMed     Abstract available


  29. AL-NAQQASH M, Jasim Al-Serarati W, Farooq Kareem T
    Trastuzumab beyond progression in HER2-positive metastatic breast cancer.
    Breast J. 2021 Jan 20. doi: 10.1111/tbj.14157.
    PubMed    


  30. SROUR MK, Qu Y, Deng N, Carlson K, et al
    Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis.
    Breast J. 2021 Jan 19. doi: 10.1111/tbj.14119.
    PubMed     Abstract available


  31. SCHMIDT H, Zhaveri S, Valente C, Pisapati K, et al
    Response in breast vs axilla after neoadjuvant treatment and implications for nonoperative management of invasive breast cancer.
    Breast J. 2021 Jan 3. doi: 10.1111/tbj.14125.
    PubMed     Abstract available


  32. DAG A, Edizsoy A
    Challenges in management of idiopathic granulomatous mastitis during the pandemic of COVID-19.
    Breast J. 2021;27:87-88.
    PubMed    


  33. FRANCESCHINI G, Sanchez AM, Scardina L, Terribile D, et al
    Mastectomy with immediate breast reconstruction during "phase 1" COVID-19 emergency: An Italian experience.
    Breast J. 2021;27:80-81.
    PubMed    


  34. CHOU CP, Pan HB, Yang TL, Chiang CL, et al
    Impact of the COVID-19 pandemic on the volume of mammography examinations in Southern Taiwan.
    Breast J. 2021;27:89-91.
    PubMed    


    December 2020
  35. IDE Y, Liu L, Miura S, Inuzuka M, et al
    Frequency of high-risk hormone receptor-positive breast cancer patients was much higher in Japanese breast cancer patients with germline BRCA1/2 mutations than in sporadic breast cancer patients.
    Breast J. 2020 Dec 30. doi: 10.1111/tbj.14150.
    PubMed    


  36. PERISTERI DV, Harissis HV
    Axillary lymph node dissection vs sentinel biopsy only among women with early-stage breast cancer and sentinel node metastasis: A systematic review and meta-analysis.
    Breast J. 2020 Dec 23. doi: 10.1111/tbj.14140.
    PubMed     Abstract available


  37. SOOD R, Kumar S, Laroiya I, Khare S, et al
    Assessment of PD-L1 expression and tumor-infiltrating lymphocytes (TILs) across molecular subtypes of triple-negative breast cancer.
    Breast J. 2020 Dec 14. doi: 10.1111/tbj.14110.
    PubMed    


  38. PABST L, Velten M, Fischbach C, Kalish M, et al
    Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
    Breast J. 2020 Dec 11. doi: 10.1111/tbj.14123.
    PubMed     Abstract available


  39. HELAL M, Mansour S, Khaled R, Bassam L, et al
    The role of automated breast ultrasound in the assessment of the local extent of breast cancer.
    Breast J. 2020 Dec 9. doi: 10.1111/tbj.14132.
    PubMed     Abstract available


  40. MASOOD S
    Is it time to address the continuous dilemma of breast cancer disparities among African Americans? A call to action.
    Breast J. 2020 Dec 7. doi: 10.1111/tbj.14124.
    PubMed    


  41. PAWASKAR RS, MacMillan F, Ong A, McBride K, et al
    Culture and breast cancer surgical decisions and experiences.
    Breast J. 2020 Dec 5. doi: 10.1111/tbj.14114.
    PubMed    


  42. MASUDA T, Nonami A, Tanaka F, Ando Y, et al
    A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated alphabeta T-cell immunotherapy in advanced breast cancer.
    Breast J. 2020 Dec 5. doi: 10.1111/tbj.14108.
    PubMed    


  43. GUVEN DC, Sahin TK, Aksoy S
    The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters.
    Breast J. 2020 Dec 4. doi: 10.1111/tbj.14126.
    PubMed    


  44. NGUYEN ML, Pius P, Dooley W, Squires R, et al
    A prospective single-institution study of intraoperative radiotherapy (IORT) for early-stage breast cancer.
    Breast J. 2020 Dec 3. doi: 10.1111/tbj.14128.
    PubMed     Abstract available


  45. MA SJ, Oladeru OT, Farrugia M, Mikucki M, et al
    Survival outcome of adjuvant chemotherapy and high 21-gene recurrence score in early-stage breast cancer.
    Breast J. 2020 Dec 3. doi: 10.1111/tbj.14130.
    PubMed     Abstract available


  46. FALCO M, Masojc B, Kram A
    Locoregional relapse is a strong prognostic indicator of distant metastatic progression in breast cancer patients after negative sentinel lymph node biopsy.
    Breast J. 2020 Dec 2. doi: 10.1111/tbj.14118.
    PubMed     Abstract available


  47. THULER LCS, de Aguiar SS, Rapozo D, Bello MA, et al
    Characteristics and prognosis of male breast cancer in Brazil: A cohort study.
    Breast J. 2020 Dec 1. doi: 10.1111/tbj.14120.
    PubMed    


    November 2020
  48. ARAIN A
    Smoking among breast cancer survivors.
    Breast J. 2020 Nov 28. doi: 10.1111/tbj.14107.
    PubMed    


  49. MURPHY LC, Quinn EM, Razzaq Z, Brady C, et al
    Assessing the accuracy of conventional gadolinium-enhanced breast MRI in measuring the nodal response to neoadjuvant chemotherapy (NAC) in breast cancer.
    Breast J. 2020 Nov 11. doi: 10.1111/tbj.14065.
    PubMed     Abstract available


  50. MCCORMICK B
    Five year results of Intrabeam intra-operative treatment for Breast Cancer, from France and not from Target A.
    Breast J. 2020 Nov 8. doi: 10.1111/tbj.14094.
    PubMed    


  51. SCHUSTER-BRUCE AT, Middleton HAR, Macpherson C, Pearce BCS, et al
    Patient satisfaction with nurse-led end of treatment telephone consultation for breast cancer during COVID-19 pandemic.
    Breast J. 2020 Nov 8. doi: 10.1111/tbj.14034.
    PubMed    


  52. COLLADO-MESA F, Kaplan SS, Yepes MM, Thurber MJ, et al
    Impact of COVID-19 on breast imaging case volumes in South Florida: A multicenter study.
    Breast J. 2020;26:2316-2319.
    PubMed    


  53. SYED A, Premi V, Varghese R, Arora M, et al
    Role of breast imaging with histopathological correlation in evaluating the response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Breast J. 2020;26:2272-2275.
    PubMed    


  54. AKRAMI M, Mojarad M, Ghoddusi Johari M, Zangouri V, et al
    Do tumor size and biologic features interact with each other?! Which one is more important to affect breast cancer prognosis? Report of a breast cancer registry.
    Breast J. 2020;26:2292-2294.
    PubMed    


    October 2020
  55. ZARWAN C, Diamond O, Lam P, Ghebremichael MS, et al
    Longitudinal study of breast cancer risk markers.
    Breast J. 2020 Oct 25. doi: 10.1111/tbj.14097.
    PubMed     Abstract available


  56. WHITLOCK AE, Allar BG, James T
    Pausing for the pandemic? The impact of deferring breast cancer surgery.
    Breast J. 2020 Oct 23. doi: 10.1111/tbj.14084.
    PubMed    


  57. NGO C, Sharifzadehgan S, Lecurieux-Lafayette C, Belhouari H, et al
    Indocyanine green for sentinel lymph node detection in early breast cancer: Prospective evaluation of detection rate and toxicity-The FLUOBREAST trial.
    Breast J. 2020 Oct 22. doi: 10.1111/tbj.14100.
    PubMed     Abstract available


  58. SALEMIS NS, Nakos G, Stavrinou N, Spiliopoulos K, et al
    Metastatic brachial plexopathy as the initial manifestation of breast cancer.
    Breast J. 2020 Oct 21. doi: 10.1111/tbj.14096.
    PubMed    


  59. QI WX, Cao L, Xu C, Zhao S, et al
    Dual HER2 blockade therapy increases the risk of developing cardiac toxicities in HER2-positive breast cancer: An up-to-date comprehensive meta-analysis.
    Breast J. 2020 Oct 21. doi: 10.1111/tbj.14098.
    PubMed    


  60. VIEIRA RADC, Navarro de Oliveira LC, Martins RM, Falcao-Junior PC, et al
    Schwannoma associated with breast cancer mimicking axillary metastasis.
    Breast J. 2020 Oct 19. doi: 10.1111/tbj.14090.
    PubMed    


  61. ATALLAH D, Moubarak M, Arab W, El Kassis N, et al
    MRI-based predictive factors of axillary lymph node status in breast cancer.
    Breast J. 2020 Oct 18. doi: 10.1111/tbj.14089.
    PubMed     Abstract available


  62. BAYRAMGIL A, Bilici A, Hamdard J, Acikgoz O, et al
    Triple-negative breast cancer presented with metastasis to the heart as first sign of recurrence.
    Breast J. 2020 Oct 18. doi: 10.1111/tbj.14091.
    PubMed    


  63. BERRAZAGA Y, Yahyaoui Y, Hamdi A, Letaief F, et al
    Breast cancer T1 in an emerging country: 325 Tunisian cases.
    Breast J. 2020 Oct 13. doi: 10.1111/tbj.14083.
    PubMed    


  64. ANDERSON SR, Tuttle RM, Markov LCNP, Johnson RM, et al
    The surgical treatment of breast cancer: A journey, not a procedure.
    Breast J. 2020 Oct 11. doi: 10.1111/tbj.14081.
    PubMed    


  65. DE GIORGI V, Venturi F, Portelli F, Maida P, et al
    Eyelid skin metastasis as first sign of breast cancer recurrence.
    Breast J. 2020 Oct 9. doi: 10.1111/tbj.14077.
    PubMed    


  66. BEKENY JC, Schreeder CA, Wirth P, Luvisa K, et al
    Factors contributing to persistent rates of contralateral prophylactic mastectomy in breast cancer patients: Examination of 1051 mastectomies across a single health system.
    Breast J. 2020 Oct 9. doi: 10.1111/tbj.14080.
    PubMed     Abstract available


  67. MOORMAN AM, Vink R, Rutgers EJT, Kouwenhoven EA, et al
    Incidence, clinical features, and outcomes of special types in breast cancer in a single institution population.
    Breast J. 2020 Oct 6. doi: 10.1111/tbj.14069.
    PubMed     Abstract available


  68. SOSA M, Saavedra P, Alonso B, Vega V, et al
    Left-handedness is not associated with breast cancer.
    Breast J. 2020 Oct 4. doi: 10.1111/tbj.14061.
    PubMed    


  69. KAPADIA S, Gudiwada SP, Kaji AH, Chlebowski RT, et al
    Can Oncotype DX testing be omitted in invasive breast cancer patients with clinicopathologic factors predicting very high pretest probability of a concordant result?
    Breast J. 2020 Oct 1. doi: 10.1111/tbj.14068.
    PubMed     Abstract available


  70. GANESH KUMAR N, Kung TA
    Guidelines for breast reconstruction during the COVID-19 pandemic: Are we considering enough evidence?
    Breast J. 2020;26:2108-2109.
    PubMed    


  71. DASH I, Pearce BCS, Armstrong S, Saunders C, et al
    Fertility preservation for women undergoing breast cancer treatment: A postcode lottery?
    Breast J. 2020;26:2117-2118.
    PubMed    


  72. XU Y, Hu X, Zhou L, Zhao Y, et al
    Effect of sequencing of preoperative systemic therapy on patients with locally advanced breast cancer.
    Breast J. 2020;26:1987-1994.
    PubMed     Abstract available


    September 2020
  73. DESSIMONI M, Pessoa C, Filho B, Vespoli H, et al
    Breast density in Brazilian women and its risk for breast cancer and tumor aggressiveness.
    Breast J. 2020 Sep 20. doi: 10.1111/tbj.14042.
    PubMed    


  74. CROWN A, Choi JH, Cole-Price A, Horowitz E, et al
    Optimizing care of breast cancer patients from low resource countries who immigrate to New York City: A case series from a large public hospital.
    Breast J. 2020 Sep 20. doi: 10.1111/tbj.14036.
    PubMed     Abstract available


  75. MA SJ, Oladeru OT, Singh AK
    Outcome of adjuvant chemotherapy in elderly patients with early-stage, hormone receptor-positive, HER-2-negative breast cancer.
    Breast J. 2020 Sep 18. doi: 10.1111/tbj.14054.
    PubMed     Abstract available


  76. WANG LC, Kuo CN, Ko Y
    Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan.
    Breast J. 2020 Sep 17. doi: 10.1111/tbj.14053.
    PubMed    


  77. VALENTE S, Al-Hilli Z, Liu Y, Greve N, et al
    Association of patient factors with time to treatment for breast cancer.
    Breast J. 2020 Sep 13. doi: 10.1111/tbj.14046.
    PubMed     Abstract available


  78. GIULIANI J, Bonetti A
    The cost-effectiveness of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer is supported by clinical evidence.
    Breast J. 2020 Sep 13. doi: 10.1111/tbj.14024.
    PubMed    


  79. MOSTAFAEI S, Vahidi Manesh P, Sadri Nahand J, Nesaei A, et al
    The role of Epstein-Barr virus-expressed genes in breast cancer development.
    Breast J. 2020 Sep 11. doi: 10.1111/tbj.14021.
    PubMed    


  80. SITTENFELD SMC, Murray E, Guo B, Tendulkar R, et al
    Treatment of diffuse cutaneous metastases from breast cancer.
    Breast J. 2020 Sep 11. doi: 10.1111/tbj.14049.
    PubMed    


  81. ACEA-NEBRIL B, Garcia-Novoa A, Garcia-Jimenez L, Escribano-Posada C, et al
    Impact of the COVID-19 pandemic on a breast cancer surgery program. Observational case-control study in a COVID-free hospital.
    Breast J. 2020 Sep 7. doi: 10.1111/tbj.14037.
    PubMed    


  82. WHITE RE, Warren L, Nakhlis F, Rosenbluth J, et al
    Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program.
    Breast J. 2020 Sep 1. doi: 10.1111/tbj.14030.
    PubMed     Abstract available


  83. LIM DW, Narod SA
    Outcomes of breast reconstruction following prophylactic bilateral mastectomy.
    Breast J. 2020;26:1637-1638.
    PubMed    


    August 2020
  84. PATWARI A, Bhatlapenumarthi V
    Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer.
    Breast J. 2020 Aug 31. doi: 10.1111/tbj.14032.
    PubMed    


  85. PASRICHA S, Menon V, Gupta G, Kamboj M, et al
    Impact of 2018 ASCO/CAP guidelines on HER-2 reporting categories of IHC and reflex FISH in breast cancer.
    Breast J. 2020 Aug 31. doi: 10.1111/tbj.14031.
    PubMed     Abstract available


  86. GHANI S, Sochat M, Luo J, Tao Y, et al
    Characteristics of male triple negative breast cancer: A population-based study.
    Breast J. 2020 Aug 27. doi: 10.1111/tbj.14023.
    PubMed     Abstract available


  87. YU J, Olsen MA, Margenthaler JA
    Indications for readmission following mastectomy for breast cancer: An assessment of patient and operative factors.
    Breast J. 2020 Aug 26. doi: 10.1111/tbj.14029.
    PubMed     Abstract available


  88. GUTKIN PM, Kapp DS, von Eyben R, Dirbas FM, et al
    Impact of mastectomy for breast cancer on spinal curvature: Considerations when treating patients with scoliosis.
    Breast J. 2020 Aug 25. doi: 10.1111/tbj.14018.
    PubMed     Abstract available


  89. GUVEN DC, Sahin TK, Aksoy S
    The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters.
    Breast J. 2020 Aug 19. doi: 10.1111/tbj.14027.
    PubMed    


  90. ODIKPO LC, Chiejina EN
    Assessment of barriers to practice of exercise among women with breast cancer in Delta State, Nigeria.
    Breast J. 2020 Aug 17. doi: 10.1111/tbj.13989.
    PubMed    


  91. MASOOD S
    Breast cancer risk assessment and management.
    Breast J. 2020 Aug 11. doi: 10.1111/tbj.14013.
    PubMed    


  92. MACHIELS M, Weytjens R, Erven K, Westerhoff JM, et al
    Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patients.
    Breast J. 2020 Aug 11. doi: 10.1111/tbj.13986.
    PubMed     Abstract available


  93. CHAHUAN B, Soza-Ried C, Farina A, Calvo FA, et al
    Management plan for breast cancer during the COVID-19 pandemic. A single-institution alternative to treat early breast cancer patients in a short time.
    Breast J. 2020 Aug 6. doi: 10.1111/tbj.13943.
    PubMed    


  94. SELLA T, Dowton AA, Meyer ME, Ruddy KJ, et al
    The utility of magnetic resonance imaging in early-stage breast cancer survivors-An institutional experience and literature review.
    Breast J. 2020 Aug 4. doi: 10.1111/tbj.13997.
    PubMed     Abstract available


  95. WOOD ME, McKinnon W, Garber J
    Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer.
    Breast J. 2020 Aug 2. doi: 10.1111/tbj.13969.
    PubMed     Abstract available


  96. CEN C, Chun J, Schnabel F
    Management of women at increased risk for breast cancer secondary to high-risk proliferative lesions and family history of the disease.
    Breast J. 2020 Aug 2. doi: 10.1111/tbj.13964.
    PubMed     Abstract available


  97. OLADERU OT, Singh AK, Ma SJ
    Association of endocrine therapy with overall survival in women with hormone receptor-positive, HER2-negative, node-negative breast cancer of favorable histology.
    Breast J. 2020 Aug 1. doi: 10.1111/tbj.13995.
    PubMed     Abstract available


  98. MASOOD S
    The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer.
    Breast J. 2020;26:1583-1588.
    PubMed     Abstract available


  99. GERLACH K, Phalak K, Patel M, Leung JWT, et al
    COVID-19: Current and future crisis planning in breast imaging.
    Breast J. 2020;26:1615-1617.
    PubMed    


  100. TESTORI A, Alloisio M, Errico V, Perroni G, et al
    Extraordinary emergency measures set up by a Breast Unit to prevent COVID-19: Report of our experience.
    Breast J. 2020;26:1611-1612.
    PubMed    


  101. SORBO G, Gagliano S, La Tessa C, Ferrarini R, et al
    Breast unit Efficacy with the relocation of the surgical breast team during the COVID-19 pandemic.
    Breast J. 2020;26:1613-1614.
    PubMed    


    July 2020
  102. BOTTY VAN DEN BRUELE A, Gemignani ML
    Management of ipsilateral supernumerary nipple at time of breast cancer diagnosis.
    Breast J. 2020 Jul 30. doi: 10.1111/tbj.13973.
    PubMed     Abstract available


  103. ARAUJO DCM, Duarte GM, Jales RM, Shinzato JY, et al
    Sentinel lymph node biopsy vs no axillary surgery in early breast cancer clinically and ultrasonographically node negative: A prospective randomized controlled trial-VENUS trial.
    Breast J. 2020 Jul 30. doi: 10.1111/tbj.13994.
    PubMed    


  104. AL AMERI M, Hachim IY, Al Hashmi FY, AlHarmoodi F, et al
    In vitro fertilization and its correlation with different breast cancer characteristics: single-center experience in Al Ain, United Arab Emirates.
    Breast J. 2020 Jul 28. doi: 10.1111/tbj.13993.
    PubMed    


  105. DE LA CRUZ-KU GA, Chambergo-Michilot D, Valcarcel B, Rebaza P, et al
    Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
    Breast J. 2020 Jul 25. doi: 10.1111/tbj.13988.
    PubMed     Abstract available


  106. GUARINO S, Stocchi L, Massaioli C
    Ribociclib therapy in peritoneal carcinomatosis secondary to HER2-negative metastatic breast cancer: A clinical case with a positive outcome.
    Breast J. 2020 Jul 25. doi: 10.1111/tbj.13940.
    PubMed     Abstract available


  107. DAMODARAN S, Sember QC, Arun BK
    Clinical implications of breast cancer tumor genomic testing.
    Breast J. 2020 Jul 22. doi: 10.1111/tbj.13966.
    PubMed     Abstract available


  108. SHAH PD, Domchek SM
    The contemporary landscape of genetic testing and breast cancer: Emerging issues.
    Breast J. 2020 Jul 20. doi: 10.1111/tbj.13968.
    PubMed     Abstract available


  109. CUFFOLO G, Gahir-Atwal HK, Smith B
    One-step nucleic acid amplification CK19 copy number for sentinel node biopsy in breast cancer: Identification of new cutoffs to predict nonsentinel axillary node involvement.
    Breast J. 2020 Jul 17. doi: 10.1111/tbj.13977.
    PubMed     Abstract available


  110. MAGNO S, Linardos M, Carnevale S, Dilucca M, et al
    The impact of the COVID-19 pandemic on breast cancer patients awaiting surgery: Observational survey in an Italian University hospital.
    Breast J. 2020 Jul 17. doi: 10.1111/tbj.13889.
    PubMed    


  111. SCIARAFFA T, Guido B, Khan SA, Kulkarni S, et al
    Breast cancer risk assessment and management programs: A practical guide.
    Breast J. 2020 Jul 14. doi: 10.1111/tbj.13967.
    PubMed     Abstract available


  112. MIR A, Mohebbi N, Omranipour R, Sedaghat M, et al
    Study of pregabalin effect on postsurgical pain in breast cancer patients: A double-blind randomized clinical trial using placebo.
    Breast J. 2020 Jul 13. doi: 10.1111/tbj.13979.
    PubMed    


  113. SHARIFI A, Seiler S, Hwang H, Dogan BE, et al
    Neoplastic seeding of breast cancer along the core biopsy tract.
    Breast J. 2020 Jul 13. doi: 10.1111/tbj.13974.
    PubMed    


  114. MIYASHITA H, Satoi S, Cruz C, Malamud SC, et al
    Neo-adjuvant therapy for triple-negative breast cancer: Insights from a network meta-analysis.
    Breast J. 2020 Jul 13. doi: 10.1111/tbj.13978.
    PubMed     Abstract available


  115. POREMBKA JH, Ma J, Le-Petross HT
    Breast density, MR imaging biomarkers, and breast cancer risk.
    Breast J. 2020 Jul 11. doi: 10.1111/tbj.13965.
    PubMed     Abstract available


  116. COLLINS JM, Isaacs C
    Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer.
    Breast J. 2020 Jul 11. doi: 10.1111/tbj.13970.
    PubMed     Abstract available


  117. LERTBUTSAYANUKUL C, Pitak M, Ajchariyasongkram N, Rakkiet N, et al
    Long-term patient-rated cosmetic and satisfactory outcomes of early breast cancer treated with conventional versus hypofractionated breast irradiation with simultaneous integrated boost technique.
    Breast J. 2020 Jul 9. doi: 10.1111/tbj.13960.
    PubMed     Abstract available


  118. DOUCETTE K, Lai C, Pohlmann PR
    Rebound lymphocytosis in a patient with chronic lymphocytic leukemia after cessation of a CDK 4/6 inhibitor for concomitant breast cancer.
    Breast J. 2020 Jul 8. doi: 10.1111/tbj.13955.
    PubMed     Abstract available


  119. DESAI NV, Tung NM
    Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier.
    Breast J. 2020 Jul 6. doi: 10.1111/tbj.13972.
    PubMed     Abstract available


  120. NGASERIN S, Chua HW, Chew MH, Tan BK, et al
    A tripartite approach can seek to optimize breast cancer management during a pandemic - Real-Time experience of a developing breast oncology unit in Singapore.
    Breast J. 2020 Jul 1. doi: 10.1111/tbj.13961.
    PubMed    


  121. SALGARELLO M, Adesi LB, Visconti G, Pagliara DM, et al
    Considerations for performing immediate breast reconstruction during the COVID-19 pandemic.
    Breast J. 2020;26:1485-1487.
    PubMed    


    June 2020
  122. CASELLA D, Fusario D, Cassetti D, Miccoli S, et al
    The patient's pathway for breast cancer in the COVID-19 era: An Italian single-center experience.
    Breast J. 2020 Jun 28. doi: 10.1111/tbj.13958.
    PubMed     Abstract available


  123. KIM E, Park B, Lee W, Min J, et al
    Metastatic breast cancer presented as great toenail pyogenic granuloma.
    Breast J. 2020 Jun 24. doi: 10.1111/tbj.13903.
    PubMed    


  124. PURI A, Reddy TP, Patel TA, Chang JC, et al
    Metastatic triple-negative breast cancer: Established and emerging treatments.
    Breast J. 2020 Jun 23. doi: 10.1111/tbj.13946.
    PubMed     Abstract available


  125. YOUSEFI KASHI AS
    Overall survival and related prognostic factors for familial breast cancer patients: A single institution study in Iran.
    Breast J. 2020 Jun 21. doi: 10.1111/tbj.13942.
    PubMed    


  126. SINDONI A, Fama F, Vinciguerra P, Gioffre-Florio M, et al
    Orbital metastasis in a male patient after seven years from breast cancer diagnosis.
    Breast J. 2020 Jun 15. doi: 10.1111/tbj.13937.
    PubMed    


  127. VAN ZEELAND M, Westhoff P, Wauters C, Bult P, et al
    Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?
    Breast J. 2020 Jun 10. doi: 10.1111/tbj.13930.
    PubMed    


  128. BROADBENT R, Ralston S, Lauder J, Howell S, et al
    Outcome of CT staging prior to neo-adjuvant chemotherapy in patients with early breast cancer.
    Breast J. 2020 Jun 10. doi: 10.1111/tbj.13931.
    PubMed    


  129. BAYRAKTAR S, Zhou JZ, Bassett R, Gutierrez Barrera AM, et al
    Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
    Breast J. 2020 Jun 4. doi: 10.1111/tbj.13922.
    PubMed     Abstract available


  130. PARISE CA, Caggiano V
    The influence of comorbidity on treatment and survival of triple-negative breast cancer.
    Breast J. 2020 Jun 2. doi: 10.1111/tbj.13924.
    PubMed     Abstract available


    May 2020
  131. ISMAILI N, El Majjaoui S
    Management of breast cancer during COVID-19 pandemic in Morocco.
    Breast J. 2020 May 30. doi: 10.1111/tbj.13925.
    PubMed    


  132. CORSI F, Caruso A, Albasini S, Bossi D, et al
    Management of breast cancer in an EUSOMA-accredited Breast Unit in Lombardy, Italy, during the COVID-19 pandemic.
    Breast J. 2020 May 30. doi: 10.1111/tbj.13926.
    PubMed    


  133. BOSSUYT V, Spring L
    Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long-term outcomes for breast cancer patients.
    Breast J. 2020 May 29. doi: 10.1111/tbj.13864.
    PubMed     Abstract available


  134. VILLASCO A, D'Alonzo M
    Extended endocrine therapy in premenopausal breast cancer patients: Where are we now?
    Breast J. 2020 May 29. doi: 10.1111/tbj.13895.
    PubMed     Abstract available


  135. TURASHVILI G, Wen HY
    Multigene testing in breast cancer: What have we learned from the 21-gene recurrence score assay?
    Breast J. 2020 May 26. doi: 10.1111/tbj.13859.
    PubMed     Abstract available


  136. CICCARESE M, Orlando L, Fedele P, Schiavone P, et al
    A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
    Breast J. 2020 May 20. doi: 10.1111/tbj.13856.
    PubMed    


  137. TASDOVEN I, Karadeniz Cakmak G
    Breast cancer surgery under the shadow of COVID-19: Quest for optimal axillary management after neo-adjuvant chemotherapy.
    Breast J. 2020 May 20. doi: 10.1111/tbj.13892.
    PubMed    


  138. BAR-SELA G, Samih Y, Yerushalmi R, Leviov M, et al
    Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis.
    Breast J. 2020 May 18. doi: 10.1111/tbj.13870.
    PubMed    


  139. BEN KRIDIS W, Khanfir A
    Delayed docetaxel extravasation in case of breast cancer.
    Breast J. 2020 May 18. doi: 10.1111/tbj.13882.
    PubMed    


  140. SAGARRA-ROMERO L
    Effects of breast cancer treatment on metabolic health.
    Breast J. 2020 May 16. doi: 10.1111/tbj.13852.
    PubMed    


  141. RAVINDHRAN B, Attigere Math H, Chalegere M, Raheem A, et al
    The efficacy of frozen gel packs on postoperative pain, and NSAID or narcotic use in patients undergoing surgery for axillary node-positive breast cancer.
    Breast J. 2020 May 10. doi: 10.1111/tbj.13871.
    PubMed    


  142. TONELLOTTO F, Bergmann A, Abrahao KS, de Aguiar SS, et al
    Lymphatic/vascular invasion has a negative impact on overall survival and disease-free survival in patients with breast cancer and positive axillary lymph nodes.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13872.
    PubMed    


  143. SALDI S, Perrucci E, Fulcheri CPL, Mariucci C, et al
    Zinc-L-carnosine prevented dysphagia in breast cancer patients undergoing adjuvant radiotherapy: Results of a phase III randomized trial.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13855.
    PubMed    


  144. PETROU P
    A systematic review of the economic evaluations of trastuzumab in metastatic breast cancer.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13853.
    PubMed    


    April 2020
  145. LE NK, Gabrick KS, Chouairi F, Mets EJ, et al
    Impact of socioeconomic status on psychological functioning in survivorship following breast cancer and reconstruction.
    Breast J. 2020 Apr 26. doi: 10.1111/tbj.13849.
    PubMed     Abstract available


  146. FOLLETTE CJ, Humphrey C, Amin A, Balanoff C, et al
    Primary tumor resection in de novo stage IV breast cancer patients.
    Breast J. 2020 Apr 26. doi: 10.1111/tbj.13850.
    PubMed     Abstract available


  147. CONLEY CC, Garcia JD, Radford C, Reich RR, et al
    Acceptability and outcomes of multigene panel testing among young Black breast cancer survivors.
    Breast J. 2020 Apr 22. doi: 10.1111/tbj.13848.
    PubMed    


  148. THORPE CS, Niska JR, Anderson JD, Girardo ME, et al
    Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysis.
    Breast J. 2020 Apr 15. doi: 10.1111/tbj.13812.
    PubMed     Abstract available


  149. CAIRNS C, Greenwalt I, Fan KL, Willey SC, et al
    Contralateral axillary sentinel lymph node in breast cancer recurrence.
    Breast J. 2020 Apr 14. doi: 10.1111/tbj.13816.
    PubMed     Abstract available


  150. CHUDASAMA R, Hsu A, Constantinou M
    Orbital metastasis in inflammatory breast cancer.
    Breast J. 2020 Apr 14. doi: 10.1111/tbj.13839.
    PubMed    


  151. SILIPIGNI S, Ippolito E, Matteucci P, Santo B, et al
    Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report.
    Breast J. 2020 Apr 11. doi: 10.1111/tbj.13844.
    PubMed     Abstract available


  152. STOFFAES L, Dumazet A, Deslee G, Mohammad Muttaqi Z, et al
    Sarcoidosis-like reaction during palbociclib treatment for metastatic breast cancer: A case report.
    Breast J. 2020 Apr 10. doi: 10.1111/tbj.13800.
    PubMed     Abstract available


  153. ECKHERT E, Laniakea B, Kurian AW
    A case of a trans-masculine patient receiving testosterone with a history of estrogen receptor-positive breast cancer.
    Breast J. 2020 Apr 7. doi: 10.1111/tbj.13829.
    PubMed    


  154. VRANIC S
    Letter to Editor: Apocrine carcinoma is the fact. Comment on the recent paper entitled "Invasive apocrine carcinoma of the breast: Myth or fact?" by Gurrado et al (Breast J. 2019;26(3):545-546.).
    Breast J. 2020;26:838.
    PubMed    


  155. GURRADO A, Serio G, Marzullo A
    Author's reply on letter to editor "Apocrine carcinoma is the fact" by Vranic S.
    Breast J. 2020;26:839-840.
    PubMed    


    March 2020
  156. TALLET A, Racadot S, Boher JM, Cohen M, et al
    The actual benefit of intraoperative radiation therapy using 50 kV x-rays in early breast cancer: A retrospective study of 676 patients.
    Breast J. 2020 Mar 31. doi: 10.1111/tbj.13827.
    PubMed     Abstract available


  157. UPADHYAY R, Pandey R, Nand Sharma D, Gupta S, et al
    Concurrent or sequential hormonal therapy in era of hypofractionation in early breast cancer: A single-institution prospective study.
    Breast J. 2020 Mar 29. doi: 10.1111/tbj.13825.
    PubMed    


  158. CARBONI F, Covello R, Carosi MA, Valle M, et al
    The diagnostic challenge of solitary ovarian mass after breast cancer.
    Breast J. 2020 Mar 24. doi: 10.1111/tbj.13819.
    PubMed    


  159. DOSTALEK L, Lednicky S, Saskova P, Steyerova P, et al
    Is it possible to abandon sentinel lymph node biopsy in breast cancer patients with negative axillary ultrasound in the post-Z0011 era? A retrospective analysis.
    Breast J. 2020 Mar 18. doi: 10.1111/tbj.13814.
    PubMed    


  160. LOMBARDI A, Vitale V, Nigri G, Olivieri C, et al
    Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
    Breast J. 2020 Mar 16. doi: 10.1111/tbj.13807.
    PubMed     Abstract available


  161. LOHANI KR, Kumar C, Kataria K, Srivastava A, et al
    Role of tranexamic acid in axillary lymph node dissection in breast cancer patients.
    Breast J. 2020 Mar 15. doi: 10.1111/tbj.13810.
    PubMed     Abstract available


  162. HOLLINGSWORTH AB, Pearce MR, Stough RG
    Breast cancer survival following MRI detection in a high-risk screening program.
    Breast J. 2020 Mar 12. doi: 10.1111/tbj.13813.
    PubMed     Abstract available


  163. VAN EGDOM LSE, Pusic A, Verhoef C, Hazelzet JA, et al
    Machine learning with PROs in breast cancer surgery; caution: Collecting PROs at baseline is crucial.
    Breast J. 2020 Mar 11. doi: 10.1111/tbj.13804.
    PubMed     Abstract available


  164. GUO LN, Gawelek KL, Russell-Goldman E, Nambudiri VE, et al
    Seeding from percutaneous liver biopsy: A case of iatrogenic cutaneous breast cancer.
    Breast J. 2020 Mar 5. doi: 10.1111/tbj.13794.
    PubMed    


  165. RODRIGUEZ PALLEIRO MC, Krygier Waltier G
    The impact of 21-Gene Recurrence Score test and classic clinical-pathologic factors in guiding adjuvant therapy for HER-2 negative, ER-positive, early-stage breast cancer: A retrospective study.
    Breast J. 2020 Mar 3. doi: 10.1111/tbj.13787.
    PubMed    


  166. KHALLAF E, Wessam R, Abdoon M
    Targeted axillary dissection of carbon-tattooed metastatic lymph nodes in combination with post-neo-adjuvant sentinel lymph node biopsy using 1% methylene blue in breast cancer patients.
    Breast J. 2020 Mar 2. doi: 10.1111/tbj.13736.
    PubMed    


  167. STRACH MC, Prasanna T, Carrigy MA, Bilton K, et al
    Impact of a novel breast cancer survivorship program on patient-centered outcomes: A single institutional study.
    Breast J. 2020 Mar 2. doi: 10.1111/tbj.13790.
    PubMed    


  168. CORACI D, Giovannini S, Loreti C, Fusco A, et al
    Management of neuropathic pain: A graph theory-based presentation of literature review.
    Breast J. 2020;26:581-582.
    PubMed    


    February 2020
  169. BEN KRIDIS W, Werda I, Mnejja W, Daoud J, et al
    Hormone resistance and breast cancer in young women: Correlated factors and survival impact.
    Breast J. 2020 Feb 26. doi: 10.1111/tbj.13795.
    PubMed    


  170. BOLAND MR, Heneghan HM, Ryan EJ, Ain Q, et al
    A systematic review and meta-analysis of the utility of lymphoscintigraphy in the management of clinically node-negative breast cancer.
    Breast J. 2020 Feb 24. doi: 10.1111/tbj.13791.
    PubMed    


  171. WEI CH, West R, Schmolze D, Apple SK, et al
    Clinical vs genomic risks in breast cancer in 2019: Breast pathologist's appellate review of the controversial results from TAILORx trial.
    Breast J. 2020 Feb 20. doi: 10.1111/tbj.13771.
    PubMed    


  172. PREAT F, Rondelli M, Delrue P, Anne-Sophie H, et al
    Contralateral axillary sentinel node: The hidden pathway in breast cancer.
    Breast J. 2020 Feb 18. doi: 10.1111/tbj.13777.
    PubMed    


  173. SILVA TB, Cardoso MAS, Ramim JE, Bergmann A, et al
    Pain-relievers prescription after bone metastasis detection in breast cancer patients: A Brazilian reference cancer hospital experience.
    Breast J. 2020 Feb 18. doi: 10.1111/tbj.13782.
    PubMed    


  174. WAKELEY ME, Bare CF, Pine R, Dube C, et al
    A social media survey of women who do not pursue reconstruction after mastectomy for breast cancer: Characterizing the "Going Flat" movement.
    Breast J. 2020 Feb 18. doi: 10.1111/tbj.13781.
    PubMed    


  175. CAO KI, Waechter L, Carton M, Kirova YM, et al
    Outcomes of exclusive radiation therapy for older women with breast cancer according to age and comorbidity status: An observational retrospective study.
    Breast J. 2020 Feb 14. doi: 10.1111/tbj.13764.
    PubMed     Abstract available


  176. LIMBACH KE, Leon E, Pommier RF, Pommier SJ, et al
    Comparison of breast cancer incidence, clinicopathologic features, and risk factor prevalence in women aged 20-29 at diagnosis to those aged 30-39.
    Breast J. 2020 Feb 14. doi: 10.1111/tbj.13783.
    PubMed    


  177. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Verdaguer P, et al
    Predictive factors for omitting lymphadenectomy in patients with node-positive breast cancer treated with neo-adjuvant systemic therapy.
    Breast J. 2020 Feb 13. doi: 10.1111/tbj.13763.
    PubMed     Abstract available


  178. ZHAO Y, Sheng M, Zheng L, Xiong D, et al
    Application of circulating tumor DNA in breast cancer.
    Breast J. 2020 Feb 12. doi: 10.1111/tbj.13775.
    PubMed     Abstract available


  179. WANG L, Da H, Li X, Ran X, et al
    Comparison of CD4/6 inhibitors, PI3K inhibitors, and mTOR inhibitors for patients with advanced HR+/HER2- Breast cancer: A network meta-analysis of 19 RCTs.
    Breast J. 2020 Feb 9. doi: 10.1111/tbj.13780.
    PubMed    


  180. WANG L, Jorns JM
    Lymphocytic mastitis mimicking breast cancer in an elderly woman.
    Breast J. 2020 Feb 7. doi: 10.1111/tbj.13774.
    PubMed    


  181. KHOURY T, Fang Y, Karabakhtsian R, Mokhtar Desouki M, et al
    The clinical significance of metastatic breast carcinoma to intramammary lymph node.
    Breast J. 2020;26:197-205.
    PubMed     Abstract available


  182. TARIQ MU, Idress R, Qureshi MB, Kayani N, et al
    Solid papillary carcinoma of breast; a detailed clinicopathological study of 65 cases of an uncommon breast neoplasm with literature review.
    Breast J. 2020;26:211-215.
    PubMed     Abstract available


  183. BOCHENEK-CIBOR J, Georgiew F, Goyal S
    A retrospective analysis on safety and effectiveness of hypofractioned post-mastectomy radiotherapy.
    Breast J. 2020;26:176-181.
    PubMed     Abstract available


  184. ALI MLEES M
    Diagnosis and surgical treatment of pathologic nipple discharge using ultrasound-guided wire localization of focal ductal dilatation.
    Breast J. 2020;26:139-143.
    PubMed     Abstract available


  185. SHAH C, Obi E, Tom MC, Manyam BV, et al
    Initial outcomes with image-guided partial breast irradiation delivered with intensity-modulated radiation therapy.
    Breast J. 2020;26:227-230.
    PubMed     Abstract available


  186. BEAULIEU-JONES BR, Ring N, Frazee TE, DiFlorio-Alexander RM, et al
    Screening vs staging magnetic resonance imaging-guided core needle breast biopsies: Does MRI indication impact upgrade rate?
    Breast J. 2020;26:216-219.
    PubMed     Abstract available


  187. LIBERALE V, Rosso R, Arisio R, D'Alonzo M, et al
    Axillary dissection in patients with preoperative positive nodal cytology: Genuine need or overtreatment?
    Breast J. 2020;26:168-175.
    PubMed     Abstract available


  188. SHIN K, Weaver O, Wei W, Caudle AS, et al
    Sonographic features of benign and malignant axillary nodes post-neoadjuvant chemotherapy.
    Breast J. 2020;26:182-187.
    PubMed     Abstract available


  189. GULDE A, Hasanov E, Krug K, Krucke GW, et al
    Everolimus-induced pneumonitis: A diagnostic challenge.
    Breast J. 2020;26:287-288.
    PubMed    


  190. HAYNES HR, Rose DSC
    Synchronous small lymphocytic lymphoma and metastatic breast carcinoma in axillary lymph nodes: Preservation of follicular architecture only in the portions of affected lymph nodes involved by metastatic carcinoma.
    Breast J. 2020;26:245-246.
    PubMed     Abstract available


  191. OTANI T, Hamada M, Hashimoto Y, Higashi C, et al
    Phyllodes tumor with extensive intraductal spread radiologically mimicking ductal carcinoma in situ.
    Breast J. 2020;26:269-270.
    PubMed    


  192. COX J, Sharma N
    Mammography volumes and performance of screen readers: Is it time for international consensus?
    Breast J. 2020;26:331-332.
    PubMed    


  193. TRIHIA HJ, Valavanis C, Novkovic N, Koutsodontis G, et al
    Polymorphous adenocarcinoma of the breast-an exceptionally rare entity: Clinicopathological description of a case and brief review.
    Breast J. 2020;26:261-264.
    PubMed    


  194. DUBOIS C, Nika E, Hoffmann P, Delouche A, et al
    Solitary fibrous tumor of the breast: A rare entity.
    Breast J. 2020;26:289-290.
    PubMed    


  195. MOSER T, Creed M, Walker R, Meier G, et al
    Radiotherapy tattoos: Women's skin as a carrier of personal memory-What do we cause by tattooing our patients?
    Breast J. 2020;26:316-318.
    PubMed    


  196. ABDEL HADI M, Al Muhanna A, Alratroot J, Shawarby MA, et al
    Angiocentric invasive ductal carcinoma: Breast images.
    Breast J. 2020;26:295-296.
    PubMed    


  197. MORENO G, Jorns JM
    Endosalpingiosis and other benign epithelial inclusions in breast sentinel lymph nodes.
    Breast J. 2020;26:274-275.
    PubMed    


  198. PUNGLIA RS, Ortiz Pimentel S, Cronin AM, Frank ES, et al
    Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction.
    Breast J. 2020;26:319-321.
    PubMed    


  199. KAUR G, Mitra S, Singh G, Bal A, et al
    Neuroendocrine carcinoma of the breast arising in malignant phyllodes tumor.
    Breast J. 2020;26:276-277.
    PubMed    


  200. MEYNARD L, Grellety T
    CDK 4/6 inhibitor successful rechallenge after limiting hepatic toxicity.
    Breast J. 2020;26:255-257.
    PubMed     Abstract available


  201. KIM JM, Jung EJ, Kim JY, Lee HS, et al
    A rare case of mixed type liposarcoma of breast arising in malignant phyllodes tumor.
    Breast J. 2020;26:271-273.
    PubMed    


  202. GARDANI M, Bellini E, Villani G, Orsi N, et al
    Breast implant-associated anaplastic large cell lymphoma: A rare case report of lymphoma in the form of a pericapsular solid formation.
    Breast J. 2020;26:247-251.
    PubMed     Abstract available


  203. GARREFFA E, Cantagalli F, Mastrantuono A, Cammarota E, et al
    Pectoral nerves blocks (PECS) and sedation: A way to avoid general anesthesia in breast surgery - A single institution early experience.
    Breast J. 2020;26:303-305.
    PubMed    


  204. BICCHIERAI G, Nori J, De Benedetto D, Boeri C, et al
    Follow-up of B3 breast lesions without residual microcalcifications post vacuum-assisted biopsy, can contrast-enhanced digital mammography help?
    Breast J. 2020;26:299-302.
    PubMed    


  205. NIA ES, Leung JWT
    Solitary palpable breast mass as the initial presentation of clinically silent extramedullary acute myeloid leukemia.
    Breast J. 2020;26:267-268.
    PubMed    


  206. BARAJAS D
    Glomus tumor of the male breast.
    Breast J. 2020;26:297-298.
    PubMed    


  207. DE FARIA LL, Brasil ST, Endo E, Chala L, et al
    Breast fibroadenoma in transgender woman.
    Breast J. 2020;26:293-294.
    PubMed    


  208. PAPAS Y, Asmar AE, Ghandour F, Hajj I, et al
    Malignant phyllodes tumors of the breast: A comprehensive literature review.
    Breast J. 2020;26:240-244.
    PubMed     Abstract available


    January 2020
  209. CORREDOR J, Woodson AH, Gutierrez Barrera A, Arun B, et al
    Multigene panel testing results in patients with multiple breast cancer primaries.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13762.
    PubMed     Abstract available


  210. BICCHIERAI G, Tonelli P, Piacenti A, De Benedetto D, et al
    Evaluation of contrast-enhanced digital mammography (CEDM) in the preoperative staging of breast cancer: Large-scale single-center experience.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13766.
    PubMed     Abstract available


  211. NOWIKIEWICZ T, Glowacka-Mrotek I, Tarkowska M, Nowikiewicz M, et al
    Failure of sentinel lymph node mapping in breast cancer patients qualified for treatment sparing axillary lymph nodes-Clinical importance and management strategy-One-center analysis.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13769.
    PubMed     Abstract available


  212. GUTKIN PM, Fero KE, Jacobson CE, Chen JJ, et al
    Health mindset is associated with anxiety and depression in patients undergoing treatment for breast cancer.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13765.
    PubMed    


  213. RAFIROIU S, Vassil A, Valente SA
    Quinolone-induced radiation recall dermatitis in breast cancer patient.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13756.
    PubMed    


  214. VALACHIS A, Garmo H, Fredriksson I, Sund M, et al
    Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control study.
    Breast J. 2020 Jan 28. doi: 10.1111/tbj.13759.
    PubMed     Abstract available


  215. FRANCINI S, Rathat G, Manna F, Pages E, et al
    Occult lesion localization by indocyanine green fluorescence for nonpalpable breast cancer.
    Breast J. 2020 Jan 28. doi: 10.1111/tbj.13760.
    PubMed    


  216. LAYTON TB, Phillips B, Remoundos DD
    Papillary breast cancer: A retrospective single-centre clinical study.
    Breast J. 2020 Jan 24. doi: 10.1111/tbj.13746.
    PubMed     Abstract available


  217. GRANT SR, Krishnamurthy S, Le-Petross C, Valero V, et al
    An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer.
    Breast J. 2020 Jan 20. doi: 10.1111/tbj.13757.
    PubMed    


  218. FRANC BL, Thombley R, Luo Y, John Boscardin W, et al
    Using diagnosis codes in claims data to identify cohorts of breast cancer patients following initial treatment.
    Breast J. 2020 Jan 20. doi: 10.1111/tbj.13758.
    PubMed    


  219. SIQUEIRA RBA, Freitas-Junior R, Lopes PS, Lagares MS, et al
    Hydrotherapy following breast cancer surgery Phase II trial on hydrotherapy in women following breast cancer surgery.
    Breast J. 2020 Jan 20. doi: 10.1111/tbj.13744.
    PubMed    


  220. MORAN MS, Truong PT
    Hypofractionated radiation treatment for breast cancer: The time is now.
    Breast J. 2020 Jan 15. doi: 10.1111/tbj.13724.
    PubMed     Abstract available


  221. MACDONALD HR
    Pregnancy associated breast cancer.
    Breast J. 2020 Jan 14. doi: 10.1111/tbj.13714.
    PubMed     Abstract available


  222. DOE S, Petersen S, Swain M
    Utilization of genetic testing in breast cancer treatment after implementation of comprehensive multi-disciplinary care.
    Breast J. 2020 Jan 9. doi: 10.1111/tbj.13747.
    PubMed     Abstract available


  223. KUMAR M, Sebai ME, Appleford C, Dekhne N, et al
    Myxoma in the axilla of a patient with a history of inflammatory breast cancer.
    Breast J. 2020 Jan 2. doi: 10.1111/tbj.13741.
    PubMed    


  224. VOGEL VG
    Breast cancer risk reduction: Notable achievements and remaining challenges.
    Breast J. 2020;26:86-91.
    PubMed     Abstract available


  225. SILVERSTEIN MJ
    Elevating your breast program to the next level.
    Breast J. 2020;26:5-10.
    PubMed     Abstract available


  226. MASOOD S
    The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
    Breast J. 2020;26:27-34.
    PubMed     Abstract available


  227. EUHUS DM
    Management of the clinically positive axilla.
    Breast J. 2020;26:35-38.
    PubMed     Abstract available


  228. MCCORMICK B
    Breast journal 2020 special issue: Post-mastectomy radiation: Tracking changes in the standard of care over 25 years.
    Breast J. 2020;26:55-58.
    PubMed     Abstract available


  229. SPIEGEL AJ, Kania K, Hamilton KL
    2020 special issue: Twenty years of breast reconstruction: Past, present, and future.
    Breast J. 2020;26:39-41.
    PubMed     Abstract available


  230. WOOD ME, Rehman HT, Bedrosian I
    Importance of family history and indications for genetic testing.
    Breast J. 2020;26:100-104.
    PubMed     Abstract available


    December 2019
  231. ORLANDI A, Aroldi F, Garutti M, Di Dio C, et al
    Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?
    Breast J. 2019 Dec 31. doi: 10.1111/tbj.13740.
    PubMed    


  232. PETRILLO A, Fusco R, Vallone P, Filice S, et al
    Digital breast tomosynthesis and contrast-enhanced dual-energy digital mammography alone and in combination compared to 2D digital synthetized mammography and MR imaging in breast cancer detection and classification.
    Breast J. 2019 Dec 30. doi: 10.1111/tbj.13739.
    PubMed     Abstract available


  233. MELNIK I, Yerushalmi R, Sobol Y, Magen A, et al
    Intraoperative radiation therapy for breast cancer-Immediate and 30-month oncological outcomes.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13708.
    PubMed     Abstract available


  234. DJOHAN R, Knackstedt R
    Collaboration between breast and reconstructive surgery in optimizing outcomes for women with breast cancer.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13723.
    PubMed     Abstract available


  235. BRUFSKY A, Mathew A
    Adjuvant bisphosphonate therapy in early-stage breast cancer-Treating the soil to kill the seed.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13730.
    PubMed     Abstract available


  236. WONG RX, Kusumawidjaja G, Tan V
    Solitary contralateral axillary metastasis in breast cancer: Is it a true distant spread?
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13733.
    PubMed    


  237. HILAL T, Mi L, Ertz-Archambault NM, Almquist DR, et al
    Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13731.
    PubMed    


  238. GIULIANO AE
    The evolution of sentinel node biopsy for breast cancer: Personal experience.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13729.
    PubMed     Abstract available


  239. AZIM HA, Ghosn M, Oualla K, Kassem L, et al
    Personalized treatment in metastatic triple-negative breast cancer: The outlook in 2020.
    Breast J. 2019 Dec 23. doi: 10.1111/tbj.13713.
    PubMed     Abstract available


  240. CARLSON GW
    The changing surgical treatment of breast cancer in the United States: The tipping point.
    Breast J. 2019 Dec 22. doi: 10.1111/tbj.13725.
    PubMed     Abstract available


  241. OHRI N, Haffty BG
    The evolution of adjuvant radiation therapy for early-stage and locally advanced breast cancer.
    Breast J. 2019 Dec 19. doi: 10.1111/tbj.13715.
    PubMed     Abstract available


  242. DIXON JM, Cartlidge CWJ
    Twenty-five years of change in the management of the axilla in breast cancer.
    Breast J. 2019 Dec 19. doi: 10.1111/tbj.13720.
    PubMed     Abstract available


  243. HUGHES KS, Zhou J, Bao Y, Singh P, et al
    Natural language processing to facilitate breast cancer research and management.
    Breast J. 2019 Dec 18. doi: 10.1111/tbj.13718.
    PubMed     Abstract available


  244. GIARRATANO T, Frezzini S, Zanocco M, Giorgi CA, et al
    Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Breast J. 2019 Dec 14. doi: 10.1111/tbj.13711.
    PubMed     Abstract available


  245. WANG L, Gao S, Li D, Ran X, et al
    CDK4/6 inhibitors plus endocrine therapy improve overall survival in advanced HR+/HER2- breast cancer: A meta-analysis of randomized controlled trials.
    Breast J. 2019 Dec 11. doi: 10.1111/tbj.13703.
    PubMed    


  246. ONER G, Altintas S, Canturk Z, Tjalma W, et al
    Triple-negative breast cancer-Role of immunology: A systemic review.
    Breast J. 2019 Dec 4. doi: 10.1111/tbj.13696.
    PubMed     Abstract available


  247. MARTINEZ-CABRIALES SA, Sade S, Shear NH
    A progressive breast skin detachment in a breast cancer survivor.
    Breast J. 2019 Dec 2. doi: 10.1111/tbj.13706.
    PubMed    


  248. JOSTE M, Arsene-Henry A, Reyal F, Amessis M, et al
    Helical tomotherapy for patients presented with implant breast reconstruction in case of adjuvant breast cancer radiotherapy: A single center experience.
    Breast J. 2019 Dec 1. doi: 10.1111/tbj.13687.
    PubMed    


    November 2019
  249. CORTES J, Twelves C
    Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: A post hoc pooled analysis.
    Breast J. 2019 Nov 29. doi: 10.1111/tbj.13686.
    PubMed     Abstract available


  250. BOUNOUS VE, Novara L, Scicchitano F, Villasco A, et al
    A retrospective analysis on 197 cases of breast cancer local recurrence: Biology, treatment, and prognosis.
    Breast J. 2019 Nov 25. doi: 10.1111/tbj.13698.
    PubMed    


  251. FUNDYTUS A, Saad N, Logie N, Roldan Urgoiti G, et al
    Breast cancer in transgender female-to-male individuals: A case report of androgen receptor-positive breast cancer.
    Breast J. 2019 Nov 20. doi: 10.1111/tbj.13655.
    PubMed     Abstract available


  252. SKOK K, Gradisnik L, Celesnik H, Potocnik U, et al
    Isolation and characterization of the first Slovenian human triple-negative breast cancer cell line.
    Breast J. 2019 Nov 20. doi: 10.1111/tbj.13695.
    PubMed    


  253. TAS F, Ozturker C
    Distichiasis in association with entropion in metastatic HER2-positive breast cancer treated by pertuzumab, trastuzumab, and docetaxel combination chemotherapy.
    Breast J. 2019 Nov 20. doi: 10.1111/tbj.13697.
    PubMed     Abstract available


  254. LANGABEER SE
    The JAK2 V617F mutation in breast cancer?
    Breast J. 2019 Nov 19. doi: 10.1111/tbj.13683.
    PubMed    


  255. NAEEM MA
    The JAK2 V617F mutation in breast cancer?
    Breast J. 2019 Nov 19. doi: 10.1111/tbj.13688.
    PubMed    


  256. FRANC BL, Thombley R, Luo Y, Boscardin WJ, et al
    Identifying tests related to breast cancer care in claims data.
    Breast J. 2019 Nov 18. doi: 10.1111/tbj.13691.
    PubMed     Abstract available


  257. SROUR MK, Gao B, Dadmanesh F, Carlson K, et al
    Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis.
    Breast J. 2019 Nov 11. doi: 10.1111/tbj.13684.
    PubMed     Abstract available


  258. AZIM HA, Dawood S, El-Saghir N, Kassem L, et al
    Understanding the benefits and challenges of first-line cyclin-dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women.
    Breast J. 2019 Nov 10. doi: 10.1111/tbj.13637.
    PubMed     Abstract available


  259. MACDONALD HR
    Managing breast cancer risk in transgender men and women: Emerging safety data and a need for more research.
    Breast J. 2019;25:1063-1065.
    PubMed    


  260. VRANIC S
    Letter to editor/comment.
    Breast J. 2019;25:1330-1331.
    PubMed    


  261. TAKALA SJ, Heikkila P, Nevanlinna H, Blomqvist C, et al
    Reply-Letter to the editor.
    Breast J. 2019;25:1332.
    PubMed    


    October 2019
  262. ARSENE HENRY A, Amessis M, Kirova YM
    Helical Tomotherapy for patients with pectus excavatum treated for early-stage breast cancer.
    Breast J. 2019 Oct 24. doi: 10.1111/tbj.13671.
    PubMed    


  263. HAMZAH JL, Tan BKT, Tan V, Madhukumar P, et al
    A pilot study comparing Sentimag/Sienna versus standard modality for sentinel lymph node identification in patients with breast cancer.
    Breast J. 2019 Oct 14. doi: 10.1111/tbj.13660.
    PubMed    


  264. PALLESCHI M, Maltoni R, Sarti S, Melegari E, et al
    Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?
    Breast J. 2019 Oct 14. doi: 10.1111/tbj.13662.
    PubMed     Abstract available


  265. LI S, Alapati A, Riba L, Fleishman A, et al
    Delayed adjuvant hormonal therapy and its impact on mortality in women with breast cancer.
    Breast J. 2019 Oct 11. doi: 10.1111/tbj.13652.
    PubMed     Abstract available


  266. YANG K, Chun M
    Radiation recall dermatitis in response to adjuvant capecitabine immediately following postoperative radiotherapy in a patient with breast cancer.
    Breast J. 2019 Oct 3. doi: 10.1111/tbj.13627.
    PubMed     Abstract available


    September 2019
  267. TURKER S, Cilbir E, Yilmaz KB, Yetisgin E, et al
    Tumor-to-tumor metastasis: Breast cancer metastasis to lung cancer.
    Breast J. 2019 Sep 29. doi: 10.1111/tbj.13558.
    PubMed    


  268. YILMAZ KB, Saydam M, Tokgoz S, Akinci M, et al
    A novel monitorization technique for nerve protection during axillary surgery of the breast cancer patients.
    Breast J. 2019 Sep 28. doi: 10.1111/tbj.13644.
    PubMed    


  269. NAVARRO LC, Falcao-Junior PC, de Rezende ASM, Vieira RADC, et al
    Occult breast cancer associated with lymph node microcalcifications.
    Breast J. 2019 Sep 28. doi: 10.1111/tbj.13630.
    PubMed    


  270. TANG CYL, Lam WW, Tan PH, Xie W, et al
    Myoepithelial hyperplasia: A rare mimic of breast cancer on (18) F-FDG PET/CT.
    Breast J. 2019 Sep 28. doi: 10.1111/tbj.13643.
    PubMed    


  271. LAFORGA JB
    Lacrimal gland metastasis from invasive lobular carcinoma (ER(+) , PR(-) , Her-2(+) ) as the first manifestation of disseminated breast cancer.
    Breast J. 2019 Sep 28. doi: 10.1111/tbj.13640.
    PubMed    


  272. UPADHYAYA VS, Lim GH, Chan EYK, Fook-Chong SMC, et al
    Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging.
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13635.
    PubMed     Abstract available


  273. OBI E, Tom MC, Manyam BV, Grobmyer SR, et al
    Outcomes with intraoperative radiation therapy for early-stage breast cancer.
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13574.
    PubMed     Abstract available


  274. SANCHEZ AM, Franceschini G, D'Archi S, De Lauretis F, et al
    Results obtained with level II oncoplastic surgery spanning 20 years of breast cancer treatment: Do we really need further demonstration of reliability?
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13490.
    PubMed     Abstract available


  275. LEHRBERG A, Bensenhaver J
    A rare presentation of bilateral, synchronous male breast cancer.
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13639.
    PubMed     Abstract available


  276. SAKIN A, Sakalar T, Sahin S, Yasar N, et al
    Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis.
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13647.
    PubMed    


  277. MO W, Ding Y, Zheng Y, Zou D, et al
    Associations between folate metabolism enzyme polymorphisms and breast cancer: A meta-analysis.
    Breast J. 2019 Sep 23. doi: 10.1111/tbj.13527.
    PubMed     Abstract available


  278. SHAH C, Tendulkar RD
    Revisiting TARGIT-A and intraoperative radiation therapy for breast cancer.
    Breast J. 2019 Sep 23. doi: 10.1111/tbj.13629.
    PubMed    


  279. KANDAGATLA P, Rizk NN, Dokic D, Kochkodan J, et al
    Patient and provider factors associated with the noninitiation of tamoxifen for young women at high-risk for the development of breast cancer.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13528.
    PubMed     Abstract available


  280. OVERGAAUW AJC, Speijers-van der Plas LM, Hendriks MP, Smorenburg CH, et al
    Outcome and feasibility of palliative chemotherapy in very elderly patients with metastatic breast cancer.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13505.
    PubMed     Abstract available


  281. REYES SA, Williams AD, Arlow RL, De La Cruz LM, et al
    Changing practice patterns of adjuvant radiation among elderly women with early stage breast cancer in the United States from 2004 to 2014.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13491.
    PubMed     Abstract available


  282. FRASSON AL, Filho AB, Lichtenfels M, de Souza ABA, et al
    Effect of intraoperative radiotherapy for early breast cancer on 10-year recurrence rates and overall survival.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13502.
    PubMed     Abstract available


  283. WALKER RK, Berry DL
    Men with breast cancer experience stigma in the waiting room.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13593.
    PubMed    


  284. PERERA N, Fernando N, Perera R, Jayasekara P, et al
    Metastatic breast cancer spread to peripancreatic lymph nodes causing biliary obstruction.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13531.
    PubMed     Abstract available


  285. MAHTANI RL
    A role for fulvestrant monotherapy in the first-line treatment of ER+ metastatic breast cancer?
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13495.
    PubMed    


  286. STEININGER R, Bouton M, Marsh J
    Masson's tumor of the breast: Rare differential for new or recurrent breast cancer-Case report, pathology, and review of the literature.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13608.
    PubMed     Abstract available


  287. RECHT A
    Breast cancer fractionation patterns: Why aren't they uniform, and should they be?
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13578.
    PubMed    


  288. ZHANG P, Du J, Fan C, Mo X, et al
    Utility of totally implantable venous access ports in patients with breast cancer.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13595.
    PubMed    


  289. SKINNER KE, Olufade T, Walker MS, Schwartzberg LS, et al
    Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancer.
    Breast J. 2019 Sep 17. doi: 10.1111/tbj.13492.
    PubMed     Abstract available


  290. BARCO NEBREDA I, Chabrera C, Garcia-Fernandez A, Gimenez N, et al
    Factors associated with the development of distant metastases in breast cancer patients-A regression model predicting organ relapse.
    Breast J. 2019 Sep 16. doi: 10.1111/tbj.13613.
    PubMed    


  291. MESSINGER J, Lee MV
    Paraneoplastic syndrome as the initial presentation for a mammographically occult breast cancer.
    Breast J. 2019 Sep 16. doi: 10.1111/tbj.13561.
    PubMed    


  292. SHAH C
    Bioimpedance spectroscopy in the detection of breast cancer-related lymphedema: An ounce of prevention.
    Breast J. 2019 Sep 13. doi: 10.1111/tbj.13618.
    PubMed    


  293. CHAN S, Sutradhar R, Yao Z, Chow E, et al
    Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13515.
    PubMed     Abstract available


  294. MAZOUNI C, Conversano A, Laplace-Builhe C, Abbaci M, et al
    Reply-To Letter to the Editor; Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13626.
    PubMed    


  295. GRANA-LOPEZ L, Herranz M, Macineira FA, Villares A, et al
    Apparent diffusion coefficient: Potential biomarker for complete response after neo-adjuvant chemotherapy in breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13589.
    PubMed    


  296. NAEEM MA, Shah TH, Zafar N, Khan M, et al
    Detection of JAK2 gene mutation in Pakistani women with triple-negative breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13609.
    PubMed    


  297. LIVINGSTON-ROSANOFF D, Hanlon B, Marka N, Vande Walle K, et al
    Time to initiation of neo-adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13625.
    PubMed     Abstract available


  298. BLACKHALL V, Bugelli M, Abbott N, Mullen R, et al
    The role of sentinel lymph node biopsy in planning adjuvant therapy for elderly women with low-risk breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13577.
    PubMed     Abstract available


  299. ABU SHAROUR L
    Psychometric evaluation of the Arabic version of the lymphedema life impact scale in breast cancer patients.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13620.
    PubMed    


  300. LEE S, Jung Y, Bae Y
    Dermoglandular rotation flap with subaxillary advancement flap as an oncoplastic technique for breast cancer.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13503.
    PubMed     Abstract available


  301. MCCORMICK B
    Changing the practice patterns of delivery of adjuvant radiation in the elderly with low-risk breast cancer: It's harder to do than you think!
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13496.
    PubMed    


  302. FRANCESCHINI G, Visconti G, Garganese G, Barone-Adesi L, et al
    Nipple-sparing mastectomy combined with endoscopic immediate reconstruction via axillary incision for breast cancer: A preliminary experience of an innovative technique.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13529.
    PubMed     Abstract available


  303. AGARWAL S, Chang DW
    Breast reconstruction in the patient with stable, metastatic breast cancer.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13596.
    PubMed    


  304. CATTIN F, Fogacci T, Frisoni G, Semprini G, et al
    Reply to: Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13607.
    PubMed    


  305. CHENG ML, See MH, Sinnadurai S, Islam T, et al
    Adherence rate and the factors contribute toward the surgical adherence of breast cancer in Malaysia.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13617.
    PubMed    


  306. KONTOS M, Kostakis ID, Constantinidou A, Parkin A, et al
    Primary endocrine treatment for breast cancer in the elderly.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13600.
    PubMed    


  307. FELIPE VC, Bitencourt AGV, Souza JA, de Azevedo MM, et al
    MRI features after radiofrequency ablation in breast cancer.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13557.
    PubMed    


  308. CHO CH, Lee KL, Cho J, Kim D, et al
    The incidence and risk factors of frozen shoulder in patients with breast cancer surgery.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13610.
    PubMed    


  309. THAINEUA V, Ansusinha T, Auamkul N, Taneepanichskul S, et al
    Impact of regular Breast Self-Examination on breast cancer size, stage, and mortality in Thailand.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13611.
    PubMed    


  310. BARCO I, Garcia-Font M, Garcia-Fernandez A, Gimenez N, et al
    A regression model to predict axillary high tumor burden in sentinel node-positive breast cancer patients.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13594.
    PubMed    


  311. FERSTENBERG M, Julian TB
    The ongoing evaluation and evolution of breast cancer surgical care.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13526.
    PubMed     Abstract available


  312. KUMARI S, Malla RR
    Recent advances in metabolomics of triple negative breast cancer.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13524.
    PubMed     Abstract available


  313. AZORIN SAMPER MDC, Hernandorena Gonzalez M, Ibanez Arias A, Diaz Sierra S, et al
    A case report of pseudoaneurysm after a core needle biopsy of breast cancer.
    Breast J. 2019 Sep 5. doi: 10.1111/tbj.13536.
    PubMed     Abstract available


  314. BOZKAYA Y, Ay B
    Toxic epidermal necrolysis associated with ribociclib in a patient with metastatic breast cancer.
    Breast J. 2019 Sep 4. doi: 10.1111/tbj.13570.
    PubMed    


  315. ELJUGA D, Milas I, Ozretic P, Stanec M, et al
    Prospective study on quality of life after oncoplastic and lumpectomy breast cancer procedures-Is there a difference?
    Breast J. 2019 Sep 4. doi: 10.1111/tbj.13585.
    PubMed    


  316. LIAW YY, Loong FS, Tan S, On SY, et al
    A retrospective study on breast cancer presentation, risk factors, and protective factors in patients with a positive family history of breast cancer.
    Breast J. 2019 Sep 4. doi: 10.1111/tbj.13520.
    PubMed     Abstract available


  317. ALTMAN AM, Nguyen DD, Johnson B, Marmor S, et al
    Intraoperative inking is superior to suture marking for specimen orientation in breast cancer.
    Breast J. 2019 Sep 3. doi: 10.1111/tbj.13508.
    PubMed     Abstract available


  318. MERRILL AL, Smith SM, Peters SB, Agnese DM, et al
    Eccrine carcinoma masquerading as metastatic breast cancer.
    Breast J. 2019 Sep 3. doi: 10.1111/tbj.13543.
    PubMed    


  319. KILLELEA BK, Evans SB, Mougalian SS, Gross CP, et al
    Association between perceived benefits and receipt of radiotherapy among older breast cancer patients.
    Breast J. 2019 Sep 3. doi: 10.1111/tbj.13518.
    PubMed     Abstract available


  320. DING DC, Sung FC, Chen W, Wang JH, et al
    Proton pump inhibitors reduce breast cancer risk in gastric ulcer patients: A population-based cohort study.
    Breast J. 2019 Sep 2. doi: 10.1111/tbj.13519.
    PubMed     Abstract available


  321. NIXON NA, Simmons C, Lemieux J, Verma S, et al
    Research priorities in metastatic breast cancer: A James Lind Alliance Priority Setting Partnership.
    Breast J. 2019 Sep 2. doi: 10.1111/tbj.13525.
    PubMed     Abstract available


    August 2019
  322. NAKHLIS F, Regan MM, Chun YS, Dominici LS, et al
    Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13509.
    PubMed     Abstract available


  323. GOOCH JC, Chun J, Kaplowitz E, Guth A, et al
    Pregnancy-associated breast cancer in a contemporary cohort of newly diagnosed women.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13510.
    PubMed     Abstract available


  324. GELMON KA, Cristofanilli M, Rugo HS, DeMichele AM, et al
    Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13516.
    PubMed     Abstract available


  325. ARCIERO C, Buhariwalla K, Liu Y, Torres MA, et al
    Time from Completion of Neo-adjuvant Chemotherapy to Surgery: Effects on Outcomes in Breast Cancer Patients.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13482.
    PubMed     Abstract available


  326. CHRISTIAN N, Heelan Gladden A, Friedman C, Gleisner-Patton A, et al
    Increasing omission of radiation therapy and sentinel node biopsy in elderly patients with early stage, hormone-positive breast cancer.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13483.
    PubMed     Abstract available


  327. HAMDY O, El-Badrawy A, Saleh GA, Metwally IH, et al
    Preoperative localization of sentinel lymph node in breast cancer patients by silver wire insertion or liquid charcoal injection guided by CT lymphography.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13511.
    PubMed     Abstract available


  328. LA ROCCA E, Meneghini E, Dispinzieri M, Fiorentino A, et al
    Hypofractionated irradiation in 794 elderly breast cancer patients: An observational study.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13489.
    PubMed     Abstract available


  329. HORWOOD C, Ma N, Hayek J, Terando AM, et al
    Does use of axillary ultrasound in clinically node-negative patients receiving neo-adjuvant systemic therapy for breast cancer lead to surgical overtreatment?
    Breast J. 2019 Aug 21. doi: 10.1111/tbj.13481.
    PubMed     Abstract available


    July 2019
  330. WALLACE AS, Keene KS, Williams CP, Jackson BE, et al
    Hypofractionated radiation in older women with breast cancer.
    Breast J. 2019 Jul 29. doi: 10.1111/tbj.13444.
    PubMed     Abstract available


  331. FARROKH D, Ameri L, Oliaee F, Maftouh M, et al
    Can ultrasound be considered as a potential alternative for sentinel lymph node biopsy for axillary lymph node metastasis detection in breast cancer patients?
    Breast J. 2019 Jul 29. doi: 10.1111/tbj.13475.
    PubMed    


  332. BAEKSTED CW, Nissen A, Knoop A, Christiansen M, et al
    Handling of symptomatic adverse events in breast cancer patients receiving adjuvant chemotherapy in a cluster randomized trial with electronic patient-reported outcomes as intervention.
    Breast J. 2019 Jul 28. doi: 10.1111/tbj.13477.
    PubMed    


  333. THORPE CS, Niska JR, Girardo ME, Kosiorek HE, et al
    Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
    Breast J. 2019 Jul 23. doi: 10.1111/tbj.13423.
    PubMed     Abstract available


  334. CONFORTI A, Schettini F, Vallone R, Di Rella F, et al
    Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.
    Breast J. 2019 Jul 23. doi: 10.1111/tbj.13474.
    PubMed    


  335. FERREIRA DA SILVA F, de Lurdes Orvalho M, Gaspar A, Viana Lopes P, et al
    Preoperative axillary lymph node staging in early breast cancer: Diagnostic efficacy and histopathology correlation.
    Breast J. 2019 Jul 23. doi: 10.1111/tbj.13471.
    PubMed    


  336. SHI ZQ, Qiu PF, Liu YB, Cong BB, et al
    Neo-adjuvant chemotherapy and axillary de-escalation management for patients with clinically node-negative breast cancer.
    Breast J. 2019 Jul 22. doi: 10.1111/tbj.13422.
    PubMed     Abstract available


  337. SHAH C, Ridner SH
    Bioimpedance spectroscopy: The breast cancer survivorship vital sign.
    Breast J. 2019 Jul 22. doi: 10.1111/tbj.13470.
    PubMed    


  338. CASTANEDA CA, Castillo M, Enciso JA, Enciso N, et al
    Role of undifferentiation markers and androgen receptor expression in triple-negative breast cancer.
    Breast J. 2019 Jul 22. doi: 10.1111/tbj.13464.
    PubMed    


  339. LEE GE, Rosenberg SM, Mayer EL, Borges V, et al
    Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer.
    Breast J. 2019 Jul 18. doi: 10.1111/tbj.13431.
    PubMed     Abstract available


  340. IWASE M, Hattori M, Sawaki M, Yoshimura A, et al
    Presence of small residual malignant lesions in pathologic complete response after neo-adjuvant chemotherapy in patients with breast cancer.
    Breast J. 2019 Jul 18. doi: 10.1111/tbj.13473.
    PubMed    


  341. KUPSIK M, Sulo S, Katz A, Memmel H, et al
    What do women really think? Patient understanding of breast cancer risk.
    Breast J. 2019 Jul 18. doi: 10.1111/tbj.13472.
    PubMed    


  342. BARCHIESI G, McCartney A, Biagioni C, Siclari O, et al
    Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution.
    Breast J. 2019 Jul 16. doi: 10.1111/tbj.13437.
    PubMed     Abstract available


  343. YIP RHL, Yong-Hing CJ, Farinha PMS, Hayes MM, et al
    Isolated intramammary Kikuchi-Fujimoto disease, a mimic of breast cancer.
    Breast J. 2019 Jul 12. doi: 10.1111/tbj.13466.
    PubMed    


  344. WEI F, Chen W, Lin X
    Efficacy and safety of adjuvant endocrine therapy in premenopausal patients with early-stage hormone receptor-positive breast cancer: A meta-analysis of randomized controlled trials.
    Breast J. 2019 Jul 12. doi: 10.1111/tbj.13465.
    PubMed    


  345. PHADKE S, Vander Weg M, Itani N, Grogan N, et al
    Breast cancer patient preferences for test result communication.
    Breast J. 2019 Jul 12. doi: 10.1111/tbj.13461.
    PubMed    


  346. PATTERSON-LOMBA O, Dalal AA, Ayyagari R, Liu O, et al
    Systematic literature review of clinical trials of endocrine therapies for premenopausal women with metastatic HR+ HER2- breast cancer.
    Breast J. 2019 Jul 9. doi: 10.1111/tbj.13345.
    PubMed     Abstract available


  347. ZNIDARIC T, Gugic J, Marinko T, Gojkovic Horvat A, et al
    Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Breast J. 2019 Jul 8. doi: 10.1111/tbj.13433.
    PubMed     Abstract available


  348. OU D, Cao L, Xu C, Kirova Y, et al
    Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast-GPA 0-2.0.
    Breast J. 2019 Jul 8. doi: 10.1111/tbj.13426.
    PubMed     Abstract available


  349. CHOTAI N, Tang S, Lim H, Lu S, et al
    Breast cancer in a female to male transgender patient 20 years post-mastectomy: Issues to consider.
    Breast J. 2019 Jul 4. doi: 10.1111/tbj.13417.
    PubMed     Abstract available


  350. HAQUE W, Verma V, Hsiao KY, Hatch S, et al
    Omission of radiation therapy following breast conservation in older (>/=70 years) women with T1-2N0 triple-negative breast cancer.
    Breast J. 2019 Jul 4. doi: 10.1111/tbj.13443.
    PubMed     Abstract available


  351. BLAES AH, Jewett PI, McKay K, Riley D, et al
    Factors associated with genetic testing in a cohort of breast cancer survivors.
    Breast J. 2019 Jul 3. doi: 10.1111/tbj.13440.
    PubMed     Abstract available


  352. MANYAM BV, Shah C, Woody NM, Reddy CA, et al
    Long-term complications and reconstruction failures in previously radiated breast cancer patients receiving salvage mastectomy with autologous reconstruction or tissue expander/implant-based reconstruction.
    Breast J. 2019 Jul 1. doi: 10.1111/tbj.13428.
    PubMed     Abstract available


  353. DONOVAN E, Dhesy-Thind S, Mukherjee S, Kucharczyk M, et al
    Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists.
    Breast J. 2019 Jul 1. doi: 10.1111/tbj.13435.
    PubMed     Abstract available


  354. WOOD ME, Garber JE, Isaacs C, Masood S, et al
    Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.
    Breast J. 2019;25:575-577.
    PubMed    


    June 2019
  355. CROWN A, Grumley J
    Biopsy-proven lymph nodes predict axillary nodal response following neoadjuvant chemotherapy in node-positive breast cancer.
    Breast J. 2019 Jun 29. doi: 10.1111/tbj.13412.
    PubMed    


  356. DREYFUSS AD, Barsky AR, Taunk NK, Clark AS, et al
    The efficacy and safety of hypofractionated radiotherapy with concurrent anti-HER-2 therapy following breast-conserving therapy for breast cancer.
    Breast J. 2019 Jun 28. doi: 10.1111/tbj.13421.
    PubMed     Abstract available


  357. PHILLIPS GSA, Gore S, Ramsden A, Furniss D, et al
    Lymphaticovenular anastomosis improves quality of life and limb volume in patients with secondary lymphedema after breast cancer treatment.
    Breast J. 2019 Jun 27. doi: 10.1111/tbj.13348.
    PubMed     Abstract available


  358. BISGIN A, Boga I, Yalav O, Sonmezler O, et al
    BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.
    Breast J. 2019 Jun 22. doi: 10.1111/tbj.13400.
    PubMed     Abstract available


  359. LI X, Kong X, Chen S, Jiang L, et al
    Enlarged para-sentinel lymph node dissection is not necessary in breast cancer patients undergoing sentinel lymph node biopsy.
    Breast J. 2019 Jun 17. doi: 10.1111/tbj.13395.
    PubMed    


  360. DIALANI V, Tseng I, Slanetz PJ, Fein-Zachary V, et al
    Potential role of abbreviated MRI for breast cancer screening in an academic medical center.
    Breast J. 2019 Jun 17. doi: 10.1111/tbj.13297.
    PubMed     Abstract available


  361. KANE G, Fleming C, Heneghan H, McCartan D, et al
    False-negative rate of ultrasound-guided fine-needle aspiration cytology for identifying axillary lymph node metastasis in breast cancer patients.
    Breast J. 2019 Jun 13. doi: 10.1111/tbj.13402.
    PubMed     Abstract available


  362. YOON EC, Schwartz C, Brogi E, Ventura K, et al
    Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system.
    Breast J. 2019 Jun 13. doi: 10.1111/tbj.13352.
    PubMed     Abstract available


  363. ZHANG J, Zhao B, Jin F
    The assessment of 8th edition AJCC prognostic staging system and a simplified staging system for breast cancer: The analytic results from the SEER database.
    Breast J. 2019 Jun 13. doi: 10.1111/tbj.13347.
    PubMed     Abstract available


  364. KHALLAF E, Abdoon M, Lotfy A, Abdalaziz Y, et al
    Methylene blue 1% as a sensitive and safe alternative for sentinel lymph node biopsy in early stage breast cancer: Results of a large pilot study.
    Breast J. 2019 Jun 13. doi: 10.1111/tbj.13401.
    PubMed    


  365. SU S, Wang C, Wang X, Li X, et al
    Prognostic value of combining lymph node ratio and number of positive lymph nodes in breast cancer: A population-based study.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13414.
    PubMed    


  366. MAXWELL J, Shats O, Aldridge J, Lyden E, et al
    The impact of the affordable care act on breast cancer care in the USA: A multi-institutional analysis.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13373.
    PubMed     Abstract available


  367. LIM SM, Kim JY, Park HS, Park S, et al
    Effect of primary tumor resection on overall survival in patients with stage IV breast cancer.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13344.
    PubMed     Abstract available


  368. AKRAMI M, Arasteh P, Tahmasebi S, Zangouri V, et al
    Response to letter to editor on "Does metaplastic breast carcinoma demonstrate a different clinicopathological behavior in our region: The Shiraz Breast Cancer Registry".
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13415.
    PubMed    


  369. JAIN AG, Guan J, FaisalUddin M, Manoucheri M, et al
    Improving breast cancer screening rates in a primary care setting.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13377.
    PubMed     Abstract available


  370. ALTUNDAG K
    Metaplastic breast cancer: Some concerns about hormone receptor status and treatment schedules.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13413.
    PubMed    


  371. DURAES M, Crochet P, Pages E, Grauby E, et al
    Surgery of nonpalpable breast cancer: First step to a virtual per-operative localization? First step to virtual breast cancer localization.
    Breast J. 2019 Jun 9. doi: 10.1111/tbj.13379.
    PubMed     Abstract available


  372. KUDELA E, Nachajova M, Danko J
    Is the HPV virus responsible for the development of breast cancer?
    Breast J. 2019 Jun 6. doi: 10.1111/tbj.13399.
    PubMed    


  373. TOVAR JR, Zandonade E, Amorim MHC
    Local recurrence-free survival in women with breast cancer who undergo breast-conserving surgery.
    Breast J. 2019 Jun 6. doi: 10.1111/tbj.13411.
    PubMed    


  374. SCHREUDER K, Middelburg JG, Aarts MJ, Merkus JWS, et al
    An actualised population-based study on the use of radiotherapy in breast cancer patients in the Netherlands.
    Breast J. 2019 Jun 4. doi: 10.1111/tbj.13376.
    PubMed     Abstract available


  375. LAFON M, Blaye C, Kind M, Bechade D, et al
    Sarcoidosis-like reaction in metastatic triple negative breast cancer treated by anti-PD-L1.
    Breast J. 2019 Jun 4. doi: 10.1111/tbj.13386.
    PubMed     Abstract available


  376. KELEMEN P, Pukancsik D, Ujhelyi M, Kovacs E, et al
    Evaluation of the central pedicled, modified Wise-pattern technique as a standard level II oncoplastic breast-conserving surgery: A retrospective clinicopathological study of 190 breast cancer patients.
    Breast J. 2019 Jun 4. doi: 10.1111/tbj.13371.
    PubMed     Abstract available


  377. REBOUCAS LM, Campos CS, D'Amico GM, Lustosa AB, et al
    Once-weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial.
    Breast J. 2019 Jun 4. doi: 10.1111/tbj.13372.
    PubMed     Abstract available


  378. KHOSRAVI-SHAHI P, Cabezon-Gutierrez L, Aparicio Salcedo MI
    State of art of advanced triple negative breast cancer.
    Breast J. 2019 Jun 2. doi: 10.1111/tbj.13369.
    PubMed     Abstract available


  379. SADEGHI M, Alamdaran SA, Daneshpajouhnejad P, Layegh P, et al
    A logistic regression nomogram to predict axillary lymph node metastasis in early invasive breast cancer patients.
    Breast J. 2019 Jun 2. doi: 10.1111/tbj.13340.
    PubMed    


  380. BEN KRIDIS W, Toumi N, Ben Salah H, Sghaier S, et al
    Therapeutic results and prognostic factors of brain metastases from breast cancer: Single center experience.
    Breast J. 2019 Jun 2. doi: 10.1111/tbj.13334.
    PubMed    


    May 2019
  381. NGUI NK, Hitos K, Hughes TMD
    Effect of the American College of Surgeons Oncology Group Z0011 trial on axillary management in breast cancer patients in the Australian setting.
    Breast J. 2019 May 27. doi: 10.1111/tbj.13343.
    PubMed     Abstract available


  382. ABDEL-RAHMAN O
    Outcomes of metastatic breast cancer patients in relationship to disease-free interval following primary treatment of localized disease; a pooled analysis of two clinical trials.
    Breast J. 2019 May 27. doi: 10.1111/tbj.13346.
    PubMed     Abstract available


  383. MOUSAVI M, Zargan J, Haji Noor Mohammadi A, Goudarzi HR, et al
    Anticancer effects of the Latrodectus dahli crude venom on MCF-7 breast cancer cell line.
    Breast J. 2019 May 26. doi: 10.1111/tbj.13332.
    PubMed    


  384. PRINSLOO S, Rebello E, Cata JP, Black D, et al
    Electroencephalographic correlates of hypnosedation during breast cancer surgery.
    Breast J. 2019 May 24. doi: 10.1111/tbj.13328.
    PubMed    


  385. LIMA PESSOA E, Costa Vilella Dos Reis M, Sayuri Yamamoto T, Ribeiro Neto M, et al
    Familial heterozygous hypobetalipoproteinemia and breast cancer risk: A systematic review and suggestions for further research.
    Breast J. 2019 May 20. doi: 10.1111/tbj.13341.
    PubMed    


  386. WOOD K, Donnenwirth R, Mills K, Tinsley HN, et al
    Cyclic GMP signaling during human lactation and breast cancer: Implications for breast cancer prevention.
    Breast J. 2019 May 20. doi: 10.1111/tbj.13339.
    PubMed    


  387. ARCIERO C, Liu Y, Gillespie T, Subhedar P, et al
    Surgery and survival in patients with stage IV breast cancer.
    Breast J. 2019 May 13. doi: 10.1111/tbj.13296.
    PubMed     Abstract available


  388. SELLAM Y, Shahadi ID, Gelernter I, Zippel D, et al
    Local recurrence of breast cancer: Salvage lumpectomy as an option for local treatment.
    Breast J. 2019 May 13. doi: 10.1111/tbj.13290.
    PubMed     Abstract available


  389. BAO J, Donovan C, Amersi F, Zhang X, et al
    Outcomes in patients with small node-negative invasive breast cancer.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13288.
    PubMed     Abstract available


  390. PLATKO K, Haas-Neill S, Aziz T, Al-Nedawi K, et al
    The role of circulating extracellular vesicles in breast cancer classification and molecular subtyping.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13309.
    PubMed     Abstract available


  391. KOVAC M, Kovac Z, Tomasevic Z, Tomic B, et al
    Breast cancer and recurrent thrombosis - Results from prospective single center study.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13326.
    PubMed    


  392. COSTA NCD, Morsch DM, Opperman CP, Spritzer PM, et al
    Biological features of breast cancer according to age at diagnosis in southern Brazil: An analysis of retrospective data of 1128 women.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13327.
    PubMed    


  393. YANG K, Park W, Ju SG, Chung Y, et al
    Heart-sparing radiotherapy with three-dimensional printing technology after mastectomy for patients with left breast cancer.
    Breast J. 2019 May 11. doi: 10.1111/tbj.13304.
    PubMed     Abstract available


  394. MILOSEVIC ZC, Nadrljanski MM, Mijalkovic SD
    Sequelae of breast pyoderma gangrenosum associated with ulcerative colitis: Impact on breast cancer screening.
    Breast J. 2019 May 11. doi: 10.1111/tbj.13318.
    PubMed    


  395. ABDEL HADI M
    Breast cancer in developing countries: The shrinking age gap.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13335.
    PubMed    


  396. PATEL A, Wang WJ, Warnack E, Joseph KA, et al
    Surgical treatment of young women with breast cancer: Public vs private hospitals.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13294.
    PubMed     Abstract available


  397. JORIS S, Fontaine C, Decoster L, Vanacker L, et al
    Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13306.
    PubMed     Abstract available


  398. DUBROVSKY E, Raymond S, Chun J, Fong A, et al
    Genomic testing in early stage invasive male breast cancer: An NCDB analysis from 2008 to 2014.
    Breast J. 2019;25:425-433.
    PubMed     Abstract available


  399. SHREENIVAS A, Shapiro CL
    Central nervous system metastases in triple-negative breast cancer: A step in the right direction.
    Breast J. 2019;25:361-362.
    PubMed    


  400. LUBIAN LOPEZ DM, Castillo Lara M, Rodriguez Rodriguez B, Butron Hinojo CA, et al
    Metabolic syndrome and prognostic factors in postmenopausal breast cancer patients.
    Breast J. 2019;25:548-551.
    PubMed    


  401. IMAMOVIC D, Bilalovic N, Skenderi F, Beslagic V, et al
    Letter to the Editor/Response.
    Breast J. 2019;25:569.
    PubMed    


  402. ALTUNDAG K
    Neo-adjuvant treatment in invasive apocrine carcinoma of the breast.
    Breast J. 2019;25:568.
    PubMed    


  403. ELIA R, Nacchiero E, Vestita M, Giudice G, et al
    "Reply to Letter to the Editor" The post-mastectomy pain syndrome-A systematic review of the treatment modalities.
    Breast J. 2019;25:566-567.
    PubMed    


    April 2019
  404. AMRO A, Chen Y, Barry R, Susick L, et al
    Distribution and Short-term Prognostic Value of the 21-gene recurrence score in African American compared to White American breast cancer patients.
    Breast J. 2019 Apr 25. doi: 10.1111/tbj.13256.
    PubMed     Abstract available


  405. JAKUBOWICZ E, Martin B, Hoffmann R, Kroncke T, et al
    EndoPredict versus uPA/PAI-1 in breast cancer: Comparison of markers and association with clinicopathological parameters.
    Breast J. 2019 Apr 18. doi: 10.1111/tbj.13258.
    PubMed     Abstract available


  406. CAPANEMA SALIBA FRANCO R, Salvador Silva HM, Faria Almeida LL, Drummond-Lage AP, et al
    Sentinel lymph node prognosis value in breast cancer.
    Breast J. 2019 Apr 15. doi: 10.1111/tbj.13271.
    PubMed    


  407. RIBA LA, Gruner RA, Alapati A, James TA, et al
    Association between socioeconomic factors and outcomes in breast cancer.
    Breast J. 2019 Apr 15. doi: 10.1111/tbj.13250.
    PubMed     Abstract available


  408. KOLACINSKA A, Herman K, Morawiec J, Paszek S, et al
    Improvement in outcomes of breast cancer patient treatment in Poland in the 21st century.
    Breast J. 2019 Apr 13. doi: 10.1111/tbj.13245.
    PubMed     Abstract available


  409. ZIAEEMEHR A, Shahidsales S, Ghosi Z, Avan A, et al
    Association of the involvement of axillary lymph nodes in HER-2/neu overexpression in patients with breast cancer.
    Breast J. 2019 Apr 11. doi: 10.1111/tbj.13282.
    PubMed    


  410. BASCH CH, MacLean SA, Garcia P, Basch CE, et al
    Readability of online breast cancer information.
    Breast J. 2019 Apr 10. doi: 10.1111/tbj.13276.
    PubMed    


  411. SOUKIAZIAN A, Hicks DG, Turner BM
    Reconsidering "low-risk" criteria for breast cancer recurrence in hormone positive patients.
    Breast J. 2019 Apr 10. doi: 10.1111/tbj.13275.
    PubMed    


  412. PORIES SE, Myers LE, Dusenbery KL, Lotz M, et al
    Simplifying surveillance for breast cancer survivors.
    Breast J. 2019 Apr 7. doi: 10.1111/tbj.13266.
    PubMed    


  413. HUNT KN, Swanson T, O'Connor MK, Sandhu NP, et al
    Detection of multicentric breast cancer using dedicated breast PET.
    Breast J. 2019 Apr 6. doi: 10.1111/tbj.13270.
    PubMed    


  414. SHAH C, Vicini F
    Accelerated partial breast irradiation-Redefining the treatment target for women with early stage breast cancer.
    Breast J. 2019 Apr 4. doi: 10.1111/tbj.13241.
    PubMed     Abstract available


  415. LEINERT E, Schwentner L, Blettner M, Wockel A, et al
    Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study.
    Breast J. 2019 Apr 3. doi: 10.1111/tbj.13231.
    PubMed     Abstract available


  416. WANG ZH, Ng HI, Teng CS, Ge ZC, et al
    Outcomes of single-port gasless laparoscopic breast-conserving surgery for breast cancer: An observational study.
    Breast J. 2019 Apr 3. doi: 10.1111/tbj.13249.
    PubMed     Abstract available


    March 2019
  417. KOZAK MM, Xiang M, Pollom EL, Horst KC, et al
    Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis.
    Breast J. 2019 Mar 29. doi: 10.1111/tbj.13251.
    PubMed     Abstract available


  418. GABANI P, Weiner AA, Hernandez-Aya LF, Khwaja S, et al
    Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.
    Breast J. 2019 Mar 28. doi: 10.1111/tbj.13230.
    PubMed     Abstract available


  419. ARENA V, Pennacchia I, Vecchio FM, Carbone A, et al
    ER-/PR+/HER2- breast cancer type shows the highest proliferative activity among all other combined phenotypes and is more common in young patients: Experience with 6643 breast cancer cases.
    Breast J. 2019 Mar 27. doi: 10.1111/tbj.13236.
    PubMed     Abstract available


  420. ANAMPA JD, McEvoy MP, Feldman S, Sparano JA, et al
    Applying the Hippocratic Oath in breast cancer-The case for promoting prevention.
    Breast J. 2019;25:187-189.
    PubMed    


    February 2019
  421. MARIANI G, Galli G, Cavalieri S, Valagussa P, et al
    Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study.
    Breast J. 2019 Feb 27. doi: 10.1111/tbj.13197.
    PubMed     Abstract available


  422. SWEETING RS, Du L, Shyr Y, Hooks MA, et al
    Income, costs, and health care utilization may influence surgical choice in early stage breast cancer.
    Breast J. 2019 Feb 25. doi: 10.1111/tbj.13223.
    PubMed    


  423. TONG M, Guo W
    Indocyanine green fluorescence-guided lumpectomy of nonpalpable breast cancer versus wire-guided excision: A randomized clinical trial.
    Breast J. 2019 Feb 22. doi: 10.1111/tbj.13207.
    PubMed     Abstract available


  424. DEFAZIO MV, Graziano FD, Lakhiani C, Pittman TA, et al
    Incidental discovery of partial Poland's sequence during mastectomy for contralateral breast cancer.
    Breast J. 2019 Feb 22. doi: 10.1111/tbj.13210.
    PubMed    


  425. LATOSINSKY S, Jenkyn KMB, Li L, Shariff SZ, et al
    Post-mastectomy radiation in node-positive breast cancer in Ontario.
    Breast J. 2019 Feb 21. doi: 10.1111/tbj.13208.
    PubMed     Abstract available


  426. KEMP E, Koczwara B, Turner J, Girgis A, et al
    Internet use and preferences among women living with advanced breast cancer.
    Breast J. 2019 Feb 21. doi: 10.1111/tbj.13203.
    PubMed     Abstract available


  427. VOHRA NA, Brinkley J, Kachare S, Muzaffar M, et al
    Reply to "Letter to the Editor" intent of surgery of the primary tumor in metastatic breast cancer remains palliative.
    Breast J. 2019 Feb 13. doi: 10.1111/tbj.13225.
    PubMed    


  428. NAIR NS, Parmar V, Badwe RA
    Intent of surgery of the primary tumor in metastatic breast cancer remains palliative.
    Breast J. 2019 Feb 13. doi: 10.1111/tbj.13224.
    PubMed    


  429. ROBERSON PNE, Southerland A, Mitchel H, Lloyd J, et al
    Factors predicting medication prescription adherence in Appalachian breast cancer patients.
    Breast J. 2019 Feb 13. doi: 10.1111/tbj.13227.
    PubMed    


  430. PAPPOT H, Baeksted C, Knoop A, Mitchell SA, et al
    Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminolo
    Breast J. 2019 Feb 13. doi: 10.1111/tbj.13204.
    PubMed     Abstract available


  431. AL ALI A, Garrido I, Le Guellec S, Duazo-Cassin L, et al
    Rapidly growing breast desmoid tumor with intra-thoracic involvement after reconstructive surgery for breast cancer.
    Breast J. 2019 Feb 12. doi: 10.1111/tbj.13212.
    PubMed     Abstract available


  432. MANSO L, Moreno Anton F, Izarzugaza Peron Y, Delgado Mingorance JI, et al
    Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.
    Breast J. 2019 Feb 8. doi: 10.1111/tbj.13199.
    PubMed     Abstract available


  433. CERBELLI B, Botticelli A, Pisano A, Campagna D, et al
    Breast cancer subtypes affect the nodal response after neoadjuvant chemotherapy in locally advanced breast cancer: Are we ready to endorse axillary conservation?
    Breast J. 2019 Feb 7. doi: 10.1111/tbj.13206.
    PubMed     Abstract available


  434. JUNG N, Kim HJ, Jung JH, Lee SW, et al
    Restaging the axilla after neo-adjuvant chemotherapy for breast cancer: Predictive factors for residual metastatic lymph node disease with negative imaging findings.
    Breast J. 2019 Feb 3. doi: 10.1111/tbj.13192.
    PubMed     Abstract available


    January 2019
  435. CHIANG PH, Tang FH, Tsai EM, Chang YC, et al
    Hormone therapy as risk factor of breast cancer modulated by diagnostic and lifestyle risk factors in Taiwan-A National Cohort study.
    Breast J. 2019 Jan 30. doi: 10.1111/tbj.13184.
    PubMed    


  436. KATAOKA A, Sawaki M, Okumura S, Onishi S, et al
    Prediction of pathological margin status using preoperative contrast-enhanced MRI in patients with early breast cancer who underwent skin-sparing mastectomy.
    Breast J. 2019 Jan 30. doi: 10.1111/tbj.13194.
    PubMed     Abstract available


  437. KIM YJ, Shin HJ, Choi ME, Lee WJ, et al
    Radiation dermatitis with foreign body reaction clinically mimics a cutaneous metastasis from breast cancer.
    Breast J. 2019;25:141-142.
    PubMed    


  438. KLAR N, Brufsky A
    Extended adjuvant therapy for early-stage breast cancer: Are there markers for its use?
    Breast J. 2019;25:7-8.
    PubMed    


  439. ABDULLAH N, O'Leary DP, Hegarty A, Albathali M, et al
    The effect of surgical site infection in immediate breast reconstruction on breast cancer recurrence.
    Breast J. 2019;25:166-168.
    PubMed    


    December 2018
  440. PEDDI P, Master SR, Dwary AD, Ravipati HP, et al
    Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13182.
    PubMed     Abstract available


  441. LOH Z, Yeo B, Williams DS, Gyorki DE, et al
    Ectopic breast cancer in the inguinal region.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13177.
    PubMed    


  442. AKRAMI M, Arasteh P, Mokhtari M, Tahmasebi S, et al
    Does metaplastic breast carcinoma demonstrate a different clinicopathological behavior in our region: The Shiraz Breast Cancer Registry.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13183.
    PubMed    


  443. OLIVEIRA NPD, Guedes TSR, Holanda AM, Reis MA, et al
    Influence of social conditions on the quality of life of female breast cancer survivors.
    Breast J. 2018 Dec 17. doi: 10.1111/tbj.13181.
    PubMed    


  444. BHANDARI A, Xia E, Wang Y, Wang O, et al
    Laparoscopy-assisted sentinel lymph node dissection in breast cancer patients.
    Breast J. 2018 Dec 14. doi: 10.1111/tbj.13172.
    PubMed    


  445. O'DELL W, Takita C, Casey-Sawicki K, Daily K, et al
    Projected clinical benefit of surveillance imaging for early detection and treatment of breast cancer metastases.
    Breast J. 2018 Dec 12. doi: 10.1111/tbj.13153.
    PubMed     Abstract available


  446. SUTHERLAND S, Meiser B, Kaur R, Mitchell G, et al
    Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.
    Breast J. 2018 Dec 7. doi: 10.1111/tbj.13157.
    PubMed     Abstract available


  447. CAO L, G Adedjouma N, Xu C, Shen KW, et al
    The role of post-mastectomy radiotherapy in elderly patients with 1-3 positive lymph nodes breast cancer: An International Retrospective Double-Center Study.
    Breast J. 2018 Dec 6. doi: 10.1111/tbj.13163.
    PubMed     Abstract available


  448. LOVASIK BP, Seidel RL, Novello M, Torres MA, et al
    Single incision for oncologic breast conserving surgery and sentinel node biopsy in early stage breast cancer: A minimally invasive approach.
    Breast J. 2018 Dec 3. doi: 10.1111/tbj.13158.
    PubMed     Abstract available


    November 2018
  449. REBLIN M, Kasting ML, Nam K, Scherr CL, et al
    Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.
    Breast J. 2018 Nov 28. doi: 10.1111/tbj.13165.
    PubMed     Abstract available


  450. GUVENC I, Whitman GJ, Liu P, Yalniz C, et al
    Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
    Breast J. 2018 Nov 16. doi: 10.1111/tbj.13151.
    PubMed     Abstract available


  451. OZKURT E, Yardimci E, Tukenmez M, Ersoy YE, et al
    Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.
    Breast J. 2018 Nov 12. doi: 10.1111/tbj.13149.
    PubMed     Abstract available


  452. SHECHTER MAOR G, Czuzoj-Shulman N, Spence AR, Abenhaim HA, et al
    Neonatal outcomes of pregnancy-associated breast cancer: Population-based study on 11 million births.
    Breast J. 2018 Nov 12. doi: 10.1111/tbj.13156.
    PubMed     Abstract available


  453. ASAGA S, Kinoshita T, Shiino S, Jimbo K, et al
    Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy.
    Breast J. 2018 Nov 9. doi: 10.1111/tbj.13148.
    PubMed     Abstract available


  454. HUNTER-SQUIRES J, Giuliano AE
    Biopsy of abnormal intramammary and axillary lymph nodes in patients without breast cancer.
    Breast J. 2018;24:867-868.
    PubMed    


  455. JEON W, Jang BS, Jeon SH, Kim JH, et al
    Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort.
    Breast J. 2018;24:920-926.
    PubMed     Abstract available


    October 2018
  456. MAZOUNI C, Koual M, De Leeuw F, Conversano A, et al
    Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2018 Oct 8. doi: 10.1111/tbj.13123.
    PubMed     Abstract available


  457. SURMELI ZG
    Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base.
    Breast J. 2018 Oct 7. doi: 10.1111/tbj.13145.
    PubMed    


  458. CROCE MV, Cermignani L, Rabassa ME, Segal-Eiras A, et al
    Factors associated with breast cancer in an Argentine city.
    Breast J. 2018 Oct 4. doi: 10.1111/tbj.13147.
    PubMed    


    September 2018
  459. MESHKAT M, Baghestani AR, Zayeri F, Khayamzadeh M, et al
    Survival probability and prognostic factors of Iranian breast cancer patients using cure rate model.
    Breast J. 2018 Sep 30. doi: 10.1111/tbj.13120.
    PubMed     Abstract available


  460. HENNEGHAN A, Phillips C, Courtney A
    We are different: Young adult survivors' experience of breast cancer.
    Breast J. 2018 Sep 27. doi: 10.1111/tbj.13128.
    PubMed    


  461. CURREY A, Patten CR, Bergom C, Wilson JF, et al
    Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations.
    Breast J. 2018 Sep 25. doi: 10.1111/tbj.13116.
    PubMed     Abstract available


  462. CRISPIN M, Udovicich C, Chan S, Wong S, et al
    Trends in genetic screening referral in breast cancer patients under the age of forty: 2001-2016.
    Breast J. 2018 Sep 24. doi: 10.1111/tbj.13130.
    PubMed    


  463. DOS SANTOS FIGUEIREDO FW, Schoueri JHM, Almeida TCDC, de Carvalho LEW, et al
    Risk factors for breast cancer mortality: Evidence from Brazil.
    Breast J. 2018 Sep 21. doi: 10.1111/tbj.13144.
    PubMed    


  464. WILSON PC, Chagpar AB, Cicek AF, Bossuyt V, et al
    Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score.
    Breast J. 2018 Sep 19. doi: 10.1111/tbj.13117.
    PubMed     Abstract available


  465. HOU Y, Nitta H, Wei L, Banks PM, et al
    PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer.
    Breast J. 2018 Sep 19. doi: 10.1111/tbj.13112.
    PubMed     Abstract available


  466. BRADLEY JA
    The current status of intraoperative radiation therapy in breast cancer: Challenges and promises.
    Breast J. 2018;24:713-714.
    PubMed    


    August 2018
  467. TAKUWA H, Hagiwara R, Takahara S, Yamauchi A, et al
    Assisted reproductive technology is effective for but does not affect the prognosis of young patients with breast cancer: Experience in a single institution.
    Breast J. 2018 Aug 16. doi: 10.1111/tbj.13083.
    PubMed     Abstract available


  468. YANG M, Barker K, Goodman D, Park HL, et al
    Effective risk communication to promote behavioral change in patients at elevated risk for breast cancer based on the Health Belief Model.
    Breast J. 2018 Aug 6. doi: 10.1111/tbj.13086.
    PubMed    


  469. POP CF, Stanciu-Pop C, Drisis S, Radermeker M, et al
    The impact of breast MRI workup on tumor size assessment and surgical planning in patients with early breast cancer.
    Breast J. 2018 Aug 3. doi: 10.1111/tbj.13104.
    PubMed     Abstract available


    July 2018
  470. PATEL S, Delikat A, Liao J, Chetlen AL, et al
    Pre- and post-magnetic resonance imaging features of suspicious internal mammary lymph nodes in breast cancer patients receiving neo-adjuvant therapy: Are any imaging features predictive of malignancy?
    Breast J. 2018 Jul 31. doi: 10.1111/tbj.13102.
    PubMed     Abstract available


  471. LOI M, Desideri I, Olmetto E, Francolini G, et al
    BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.
    Breast J. 2018 Jul 31. doi: 10.1111/tbj.13100.
    PubMed     Abstract available


  472. SOARES LR, Freitas-Junior R
    The impact of mammography screening on the surgical treatment of breast cancer.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13093.
    PubMed    


  473. HANNAN E, Peter O'Leary D, Cheung C, Buhamad F, et al
    Knowledge of breast cancer risk factors, screening, and treatment methods in patients attending the breast clinic: A survey of 1,018 women.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13082.
    PubMed    


  474. MANNU GS, Gammer B, Bettencourt-Silva JH, Tsoti SM, et al
    Prognostic factors for male breast cancer: A breast center's 10-year experience.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13081.
    PubMed    


  475. TJALMA WAA
    When to perform a sentinel node biopsy in breast cancer patients undergoing neo-adjuvant chemotherapy?
    Breast J. 2018 Jul 26. doi: 10.1111/tbj.13088.
    PubMed    


  476. ALTUNDAG K
    Extent of metastases other than brain metastases may affect outcome in a breast cancer patients underwent resection of a brain metastases.
    Breast J. 2018 Jul 26. doi: 10.1111/tbj.13094.
    PubMed    


  477. VUGTS G, Van den Heuvel F, Maaskant-Braat AJG, Voogd AC, et al
    Predicting breast and axillary response after neoadjuvant treatment for breast cancer: The role of histology vs receptor status.
    Breast J. 2018 Jul 22. doi: 10.1111/tbj.13085.
    PubMed     Abstract available


  478. AZIM HA, Lasheen S, Kassem L
    Treatment of HER2-positive early breast cancer: How to best balance efficacy and toxicity?
    Breast J. 2018;24:459-461.
    PubMed    


    May 2018
  479. MELNOV S, Murphy P, Foley T, Nadyrov E, et al
    Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13056.
    PubMed    


  480. CAUGHRAN J, Braun TM, Breslin TM, Smith DR, et al
    The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13034.
    PubMed     Abstract available


  481. MANSOORI Y, Tabei MB, Askari A, Izadi P, et al
    Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13067.
    PubMed     Abstract available


  482. BALAGAMWALA EH, Manyam BV, Leyrer CM, Karthik N, et al
    Most patients are eligible for an alternative to conventional whole breast irradiation for early-stage breast cancer: A National Cancer Database Analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13051.
    PubMed     Abstract available


  483. MARIANI M, George K
    Neuropsychological and self-reporting outcomes following rehabilitation of cognitive dysfunction in survivors of breast cancer: A pilot study involving survivor-partner dyads.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13060.
    PubMed    


  484. BELAID I, Fatma LB, Ezzairi F, Hochlaf M, et al
    Trends and current challenges of breast cancer in Tunisia: a retrospective study of 1262 cases with survival analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13062.
    PubMed    


  485. WHITE MC, Soman A, Weinberg CR, Rodriguez JL, et al
    Factors associated with breast MRI use among women with a family history of breast cancer.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13063.
    PubMed     Abstract available


  486. KODAGANUR S, Paga U, Ram A, Krishna A, et al
    Feasibility, safety, and clinical outcomes following latissimus dorsi flap reconstruction in breast cancer- an Institutional study.
    Breast J. 2018 May 8. doi: 10.1111/tbj.13059.
    PubMed    


  487. MCCORMICK B
    It is time to personalize local treatment options for women with "good risk" DCIS.
    Breast J. 2018;24:231-232.
    PubMed    


  488. CAVIGGIOLI F, Klinger F, Lisa A, Rimondo A, et al
    The post-mastectomy pain syndrome-A systematic review of the treatment modalities.
    Breast J. 2018;24:451-452.
    PubMed    


    April 2018
  489. MURATA T, Jinno H, Takahashi M, Shimoda M, et al
    Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrence.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13033.
    PubMed     Abstract available


  490. LARSON KE, Grobmyer SR, Valente SA
    Evaluation of recurrence patterns and survival in modern series of young women with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13041.
    PubMed     Abstract available


  491. JIANG Z, Yang Y, Li S, Pan Z, et al
    A case of tonsillar metastasis from breast cancer and literature review.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13045.
    PubMed    


  492. KAIDAR-PERSON O, Marks LB, Jones EL
    Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13044.
    PubMed     Abstract available


  493. SCHNAPPER G, Marotti L, Casella D, Mano MP, et al
    Data managers: A survey of the European Society of Breast Cancer Specialists in certified multi-disciplinary breast centers.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13043.
    PubMed     Abstract available


    March 2018
  494. YOON HJ, Kim Y, Chung J, Kim BS, et al
    Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
    Breast J. 2018 Mar 30. doi: 10.1111/tbj.13032.
    PubMed     Abstract available


  495. KIM R, Kawai A, Wakisaka M, Funaoka Y, et al
    Outcomes of outpatient breast cancer surgery at a private breast clinic.
    Breast J. 2018 Mar 14. doi: 10.1111/tbj.13012.
    PubMed     Abstract available


  496. KEIM-MALPASS J, Doede A, Camacho F, Kennedy C, et al
    Impact of patient health literacy on surgical treatment of breast cancer.
    Breast J. 2018 Mar 14. doi: 10.1111/tbj.13011.
    PubMed     Abstract available


  497. CHO E, Wu Q, Rubinstein L, Linden H, et al
    Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.
    Breast J. 2018 Mar 13. doi: 10.1111/tbj.13013.
    PubMed     Abstract available


  498. HANLEY BP, Walsh SM, O'Leary DP, MacNally SP, et al
    The significance of receptor status discordance between breast cancer primary and brain metastasis.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13028.
    PubMed    


  499. DIALANI V, Westra C, Venkataraman S, Fein-Zachary V, et al
    Indications for biopsy of imaging-detected intramammary and axillary lymph nodes in the absence of concurrent breast cancer.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13009.
    PubMed     Abstract available


  500. VIEIRA RADC, Silveira SFDS, Silva DRD, Tramonte MS, et al
    Knowledge and attitudes about breast cancer care in female inmates in Sao Paulo State/Brazil.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13025.
    PubMed    


  501. BARCO I, Fraile M, Vidal M, Cambra MJ, et al
    Tamoxifen induced radiation recall dermatitis in a breast cancer patient.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13014.
    PubMed    


  502. O'SHEA E, O'Reilly S, Smiddy P
    Rare imaging appearance of skeletal metastases in a 61-year-old breast cancer patient.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13019.
    PubMed    


  503. CLIFTON K, Barnett C, Martinez A, Karuturi M, et al
    Severe hyponatremia following cyclophosphamide infusion in breast cancer patients.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13026.
    PubMed    


  504. KAMAL M, Nafie EHO, Elsers S, Alanwar S, et al
    Ethnicity influences breast cancer stem cells' drug resistance.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13021.
    PubMed    


  505. VOHRA NA, Brinkley J, Kachare S, Muzaffar M, et al
    Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13005.
    PubMed     Abstract available


  506. TOZBIKIAN GH, Zynger DL
    HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13004.
    PubMed     Abstract available


  507. SMITH IORFIDO SM, Makariou E
    Empyema necessitans mimicking inflammatory breast cancer-An unusual case of breast edema.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13015.
    PubMed    


  508. YADAV S, Jinna S, Pereira-Rodrigues O, Reeves A, et al
    Impact of preoperative BRCA1/2 testing on surgical decision making in patients with newly diagnosed breast cancer.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13007.
    PubMed     Abstract available


  509. UNKART JT, Proudfoot J, Wallace AM
    Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13002.
    PubMed     Abstract available


  510. BORDERS MH
    Breast MRI and BI-RADS category 3: Is it appropriate?
    Breast J. 2018;24:107-108.
    PubMed    


  511. NADEEM R
    Prepectoral implant-based breast reconstruction; complete acellular dermal matrix wrap or anterior circumferential cover.
    Breast J. 2018;24:223-224.
    PubMed    


    February 2018
  512. NOWIKIEWICZ T, Zegarski W, Pagacz K, Nowacki M, et al
    Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis.
    Breast J. 2018 Feb 24. doi: 10.1111/tbj.12997.
    PubMed     Abstract available


  513. CAMPBELL A, Heydarian R, Ochoa C, Dwivedi AK, et al
    Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Breast J. 2018 Feb 14. doi: 10.1111/tbj.12951.
    PubMed     Abstract available


  514. SWINTELSKI C, Plaza M
    Successful cryoablation of breast cancer.
    Breast J. 2018 Feb 7. doi: 10.1111/tbj.12996.
    PubMed     Abstract available


    January 2018
  515. WEINER A, D'Andrea GM
    Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
    Breast J. 2018 Jan 22. doi: 10.1111/tbj.12972.
    PubMed     Abstract available


  516. BARROU J, Tallet A, Cohen M, Bannier M, et al
    Contribution of intraoperative radiotherapy (IORT) for therapeutic de-escalation in early breast cancer: Report of a single institution's experience.
    Breast J. 2018 Jan 22. doi: 10.1111/tbj.12993.
    PubMed     Abstract available


  517. COOPEY SB, Acar A, Griffin M, Cintolo-Gonzalez J, et al
    The impact of patient age on breast cancer risk prediction models.
    Breast J. 2018 Jan 8. doi: 10.1111/tbj.12976.
    PubMed     Abstract available


    December 2017
  518. DECOSTER L, Fontaine C, Vanacker L, Schallier D, et al
    Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12990.
    PubMed    


  519. GARG M, Prabhakar N, Singla V, Singh T, et al
    Breast cancer in a patient with neurofibromatosis type 1.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12987.
    PubMed    


  520. FONSECA V, Brito M
    Starting hormone therapy immediately after histological diagnosis of breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12995.
    PubMed    


  521. MERCKEL LG, Verburg E, van der Velden BHM, Loo CE, et al
    Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12984.
    PubMed     Abstract available


  522. MARTIN-ROMANO P, Baraibar I, Espinos J, Legaspi J, et al
    Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12975.
    PubMed     Abstract available


  523. HWANG E, Yap ML, Boxer MM, Chong S, et al
    Variations in breast cancer histology and treatment patterns between the major ethnic groups of South West Sydney.
    Breast J. 2017 Dec 19. doi: 10.1111/tbj.12973.
    PubMed     Abstract available


  524. PASRICHA S, Gupta G, Garg R, Sharma A, et al
    Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12981.
    PubMed     Abstract available


  525. KAIDAR-PERSON O, Deal AM, Anders CK, Ewend MG, et al
    The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12919.
    PubMed    


  526. KUMAR RV, Bhasker S
    A peek into epidemiology, screening, management of breast cancer in developing countries: Experience from two regional cancer centers in India.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12965.
    PubMed    


  527. BAYO J, Avino V, Toscano F, Jimenez F, et al
    Toxicity of docetaxel, carboplatin, and trastuzumab combination as adjuvant or neo-adjuvant treatment for Her2 positive breast cancer patients and impact of colony-stimulating factor prophylaxis.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12927.
    PubMed     Abstract available


    November 2017
  528. LI T, Tang L, Gandomkar Z, Heard R, et al
    Mammographic density and other risk factors for breast cancer among women in China.
    Breast J. 2017 Nov 29. doi: 10.1111/tbj.12967.
    PubMed    


  529. WEINBERG MS, Shachar SS, Muss HB, Deal AM, et al
    Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population.
    Breast J. 2017 Nov 15. doi: 10.1111/tbj.12952.
    PubMed     Abstract available


  530. PASSHAK M, Shachar SS, Bar-Sela G, Fried G, et al
    Breast cancer in young women aged 35 and under: Patterns of care and outcome.
    Breast J. 2017 Nov 15. doi: 10.1111/tbj.12966.
    PubMed    


  531. HLUBOCKY J, Bhavnagri S, Swinford A, Mitri C, et al
    Does the use of pretreatment MRI change the management of patients with newly diagnosed breast cancer?
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12946.
    PubMed     Abstract available


  532. SALERNO C, Vento AR, Giacchino M, Lissidini G, et al
    Intra-operative radiotherapy management for breast cancer treatment in patients with pseudoxanthoma elasticum: A case report.
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12944.
    PubMed     Abstract available


  533. SHAGISULTANOVA E, Mayordomo J, Elias AD
    Triple-negative breast cancer in the elderly.
    Breast J. 2017;23:627-629.
    PubMed    


    October 2017
  534. WHITWORTH PW, Cooper A
    Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12939.
    PubMed     Abstract available


  535. MERRILL RM
    Conditional relative survival among female breast cancer patients in the United States.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12933.
    PubMed    


  536. OBA T, Ono M, Iesato A, Hanamura T, et al
    Chylous leakage after axillary lymph node dissection in a patient with breast cancer.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12934.
    PubMed    


  537. KHOURY A, Parihar V, O'steen L, Cherabuddi K, et al
    Pertuzumab and trastuzumab infusion related cytokine release syndrome in a chemotherapy naive patient with metastatic breast cancer.
    Breast J. 2017 Oct 13. doi: 10.1111/tbj.12943.
    PubMed     Abstract available


    September 2017
  538. BIGNON L, Fricker JP, Nogues C, Mouret-Fourme E, et al
    Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
    Breast J. 2017 Sep 19. doi: 10.1111/tbj.12887.
    PubMed     Abstract available


  539. OTA K, Rivera C, Martin M
    Specimen mammography distorts margin status in patients undergoing breast conserving surgery for early-stage breast cancer.
    Breast J. 2017 Sep 15. doi: 10.1111/tbj.12920.
    PubMed    


  540. TANG HKC, Lee DYH, Thompson I, Ingram JR, et al
    Delayed and localized pemphigus vulgaris after breast cancer radiotherapy.
    Breast J. 2017 Sep 11. doi: 10.1111/tbj.12910.
    PubMed     Abstract available


  541. LEE AY, Joe BN, Price ER
    The Predicament of the Probably Benign Breast MRI: Should We Rely on Intuition?
    Breast J. 2017;23:501-503.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: